Exercise and Physical Activity
A Comprehensive Analysis of Exercise Modalities, Physiological and Neurobiological Mechanisms, Fitness Assessment Technologies, and Evidence-Based Prescription Protocols
Exercise is the single most powerful pharmacological-free intervention available for human health and longevity. A single bout of moderate-intensity aerobic exercise triggers an acute cascade of over 700 molecular changes—altering gene expression, releasing myokines and exerkines, remodelling cardiac muscle, stimulating neurogenesis, and activating anti-inflammatory pathways that persist for 24-72 hours post-exercise. No pharmaceutical agent replicates this breadth of systemic benefit [1,2,3].
This chapter provides a comprehensive technical analysis of exercise across four primary modalities—aerobic, anaerobic, high-intensity interval training (HIIT), and high-intensity resistance training (HIRT)—examining each through the lens of exercise physiology, musculoskeletal anatomy, substrate metabolism, cardiovascular adaptation, neurobiological signalling, and longevity science. Evidence grading follows the A-D system used throughout this textbook [4,5,6].
The physical health benefits of regular exercise are grounded in Grade A evidence across virtually every major disease category: cardiovascular disease, type 2 diabetes, certain cancers, osteoporosis, and all-cause mortality. The dose-response relationship follows a steep initial curve—the greatest mortality reduction (30-35%) is achieved moving from sedentary to moderate activity—with diminishing but persistent returns at higher volumes [7,8,9].
The mental health effects of exercise are equally profound and increasingly understood at a molecular level. Brain-derived neurotrophic factor (BDNF), the primary mediator of exercise-induced neuroplasticity, is upregulated 2-3 fold following moderate aerobic exercise. This single molecule drives hippocampal neurogenesis, enhances synaptic plasticity, and has demonstrated antidepressant efficacy comparable to pharmacological agents in randomised controlled trials [10,11,12].
The chapter details complete exercise regimes across three fitness levels (beginner, intermediate, advanced) for multiple target outcomes including fat loss, muscle hypertrophy, endurance capacity, strength, cardiovascular fitness, and longevity optimisation. A dedicated section examines the full spectrum of fitness assessment technologies—from gold-standard laboratory methods (DEXA, VO2MAX, MRI) through emerging consumer technologies (continuous glucose monitors, AI motion capture, epigenetic clocks)—providing a framework for objective progress tracking [13,14,15].
A final section addresses the latest research frontiers: Zone 2 training and mitochondrial biogenesis, blood flow restriction (BFR) training, exerkine biology, concurrent training protocols, exercise-circadian timing interactions, and genomic personalisation of exercise prescription. These emerging fields are redefining how we understand and prescribe physical activity [16,17,18].
- FOUNDATIONS OF EXERCISE PHYSIOLOGY AND ANATOMY
Skeletal Muscle Architecture and Fibre Types
Skeletal muscle comprises approximately 40% of total body mass in healthy adults and is the primary effector organ in exercise. Structurally, muscle fibres (myofibres) are multinucleated syncytial cells containing parallel arrays of myofibrils—each composed of repeating sarcomere units. The sarcomere, the functional unit of contraction, consists of interleaved thick (myosin) and thin (actin) filaments that generate force through the cross-bridge cycle: myosin heads bind actin, undergo a power stroke consuming one ATP, release, and rebind in a cyclic process driven by calcium availability from the sarcoplasmic reticulum [19,20,21].
Human skeletal muscle contains three primary fibre types, each with distinct contractile and metabolic properties. Type I (slow-twitch) fibres are rich in mitochondria and oxidative enzymes, express myosin heavy chain isoform I (MHC-I), contract slowly (50-100 ms twitch), generate moderate force, and are highly fatigue-resistant—they form the dominant fibre population in postural muscles and are preferentially recruited during sustained low-intensity exercise. Type IIa (fast-twitch oxidative-glycolytic) fibres express MHC-IIa, contract rapidly (30-50 ms), produce higher force than Type I, possess intermediate oxidative capacity, and fatigue at moderate rates. Type IIx (fast-twitch glycolytic) fibres express MHC-IIx, produce the highest contractile velocities and peak forces, rely predominantly on anaerobic glycolysis, and fatigue rapidly—they are recruited during maximal-effort, high-velocity, or very heavy resistance movements [22,23,24].
The ratio of fibre types is genetically determined but modifiable through training. Endurance training promotes Type I fibre hypertrophy and can shift some Type IIx fibres toward a Type IIa phenotype through myosin heavy chain isoform switching. Resistance training promotes hypertrophy across all fibre types but particularly Type II fibres. This plasticity is critical to understanding how different exercise modalities produce different adaptations [25,26].
The Motor Unit and Neuromuscular Recruitment
A motor unit consists of a single motor neuron and all muscle fibres it innervates. The size principle of motor unit recruitment (Henneman, 1957) dictates that motor units are recruited in order of increasing size: small, slow-firing Type I motor units are recruited first at low force demands, followed by larger Type IIa units at moderate demands, and finally large, high-threshold Type IIx units only at near-maximal force or velocity requirements. This recruitment hierarchy has profound implications for exercise design—low-intensity exercise preferentially loads Type I fibres, while heavy resistance or maximal-velocity movements are required to engage Type IIx fibres [27,28,29].
Rate coding—the frequency of action potential firing by motor neurons—modulates force production within recruited motor units. At low firing rates (6-12 Hz), individual twitches produce low force; at higher rates (30-60 Hz), temporal summation produces sustained, graded force. Maximum voluntary contraction (MVC) requires both maximal recruitment and maximal rate coding, engaging the full neuromuscular system. This is why training at or near failure is necessary to achieve complete motor unit recruitment and maximal neural drive [30,31].
Energy Systems: The ATP Triad
Bradshaw, Alleabelle & Lawton, Jennifer. (2023). Exploitation of K ATP channels for cardiac surgery. Vessel Plus. 7. 10.20517/2574-1209.2023.121.
Electron transport chain with KATP channel and actions of MitoSNO and diazoxide. The schema simplifies the activity of the inner membrane of the mitochondrion, including the proposed KATP channel and electron transport chain. At the bottom of the figure, a photo taken by electron microscopy from the Lawton laboratory, of individual mitochondria. In the schema, diazoxide is depicted as having an inhibitory effect on Complex II (succinate dehydrogenase) while activating the KATP channel. The cardioprotection by diazoxide may occur due to either of the mechanisms or another mechanism. MitoSNO has an inhibitory effect on Complex I, which prevents SDH accumulation, and this is thought to be the cardioprotective mechanism of MitoSNO. While each is cardioprotective via these mechanisms, these two agents have a synergistic negative effect[126]. This figure is used with permission from Elsevier (obtained September 4, 2023, license number 5621920353581)[126]. MitoSNO: Mitochondria-targeted S-nitrosating agent; NADH: nicotinamide adenine dinucleotide, reduced form; NADþ: nicotinamide adenine dinucleotide, oxidized form; ROS: reactive oxygen species; ATP: adenosine triphosphate; ADP: adenosine diphosphate; Cyt C: cytochrome C.
All muscular work is powered by the hydrolysis of adenosine triphosphate (ATP) to adenosine diphosphate (ADP) and inorganic phosphate. Muscle fibres contain only enough ATP for approximately 1-2 seconds of maximal contraction; therefore, ATP must be continuously regenerated through three energy systems operating in parallel with different rates and capacities [32,33,34].
The phosphocreatine (ATP-PC) system regenerates ATP from creatine phosphate (PCr) via the enzyme creatine kinase, without oxygen and without intermediate metabolites. This system dominates ATP supply for the first 6-10 seconds of maximal effort (sprinting, Olympic lifting), providing approximately 50% of energy for a 10-second all-out sprint. PCr
stores (~20 mmol/kg wet muscle) are depleted within 10-15 seconds at maximal intensity but recover 50% within 30 seconds and 95% within 5 minutes at rest [35,36].
Anaerobic glycolysis breaks down muscle glycogen (or blood glucose) to pyruvate, which is converted to lactate when oxygen delivery is insufficient for pyruvate oxidation via the TCA cycle. This system operates without oxygen, regenerating NAD+ from NADH (required to continue glycolysis) through lactate dehydrogenase (LDH). It provides the majority of ATP during 10 seconds to 2 minutes of near-maximal effort and generates ATP at rates approximately 3-4 times faster than aerobic oxidation but produces only 2 ATP per glucose molecule versus 30-32 from complete oxidation [37,38]. Aerobic oxidation—via glycolysis, pyruvate dehydrogenase, the TCA cycle, and oxidative phosphorylation in mitochondria—provides the vast majority of ATP during exercise lasting beyond 2-3 minutes. Substrates include muscle and liver glycogen, blood glucose, fatty acids (via beta-oxidation), and to a lesser extent amino acids and ketone bodies. The relative contribution of fat versus carbohydrate oxidation depends on exercise intensity (higher intensity shifts utilisation toward carbohydrate), duration (prolonged exercise increases fat oxidation as glycogen depletes), fed/fasted state, and training status (trained individuals oxidise fat more efficiently at equivalent workloads) [39,40,41].
The Citric Acid (KREBS) Cycle
-
Acetyl-CoA (2C) enters the cycle
-
Combines with Oxaloacetate (4C) → Citrate (6C)
-
Sequential steps:
-
Citrate
-
Isocitrate
-
α-Ketoglutarate
-
Succinyl-CoA
-
Succinate
-
Fumarate
-
Malate
-
Oxaloacetate (regenerated)
-
-
Out puts per turn:
-
3 NADH
-
1 FADH₂
-
1 GTP (or ATP)
-
2 CO₂
-
MNEMONIC - “Can I Keep Selling Sex For Money, Officer?”
Cardiovascular and Respiratory Adaptations
During exercise, cardiac output (CO) must increase dramatically to deliver oxygen and substrates to working muscle. CO = stroke volume (SV) x heart rate (HR). At rest, CO is approximately 5 L/min; during maximal exercise in trained individuals it can reach 20-25 L/min or higher. The initial increase is driven primarily by sympathetic nervous system activation increasing HR and contractility. As exercise continues, venous return increases (the muscle pump and respiratory pump augment venous return from the periphery), enhancing end-diastolic volume and, via the Frank-Starling mechanism, increasing stroke volume [42,43,44].
Chronic aerobic training produces cardiac adaptations known as the athlete's heart: increased left ventricular volume (eccentric hypertrophy), increased stroke volume at rest and during exercise, reduced resting heart rate (due to increased vagal tone and reduced sympathetic drive), and enhanced diastolic filling. These adaptations represent the most efficient cardiac phenotype for sustained oxygen delivery and are partially reversible with detraining within 3-6 months [45,46].
Respiratory adaptations to training include increased tidal volume, improved ventilatory efficiency (reduced VE/VCO2), strengthened respiratory muscles, and enhanced gas exchange efficiency at the alveolar level through increased pulmonary capillary density. The ventilatory threshold (VT1) and anaerobic threshold (VT2/OBLA) shift rightward with training, meaning higher absolute workloads can be sustained before the onset of anaerobic metabolism and excessive CO2 production [47,48].
- MODES OF EXERCISE: A TECHNICAL TAXONOMY
Zone 1
Recovery
50–60% HRmax
Zone 2
Aerobic Base
60–70% HRmax
Zone 3
Tempo
70–80% HRmax
Zone 4
Threshold
80–90% HRmax
Zone 5
VO₂ Max
90–100% HRmax
Aerobic Exercise
Aerobic exercise is defined by its reliance on oxidative phosphorylation as the primary ATP regeneration pathway, maintaining exercise intensity below or at the anaerobic threshold. This encompasses a broad spectrum of activities including walking, cycling, swimming, running, rowing, and elliptical training at moderate intensities sustained for 10 minutes to several hours. The defining physiological characteristic is the ability to maintain a steady state where oxygen consumption matches oxygen delivery, and heart rate and oxygen uptake stabilise [49,50,51].
Zone 2 training—exercise at 60-70% of maximum heart rate, corresponding to approximately 55-70% of VO2MAX—has emerged as a cornerstone of longevity-oriented exercise prescription. At this intensity, the primary fuel source is fatty acid oxidation (60-90% of substrate), mitochondrial density increases through PGC-1alpha activation, and the training stimulus targets Type I slow-twitch fibres maximally without inducing excessive sympathetic nervous system activation or inflammatory response. Recent research demonstrates that Zone 2 training produces superior mitochondrial biogenesis compared to higher-intensity modalities when matched for duration [52,53,54].
Continuous steady-state aerobic exercise at moderate intensities (Zone 3, 70-80% max HR) provides the traditional endurance training stimulus, improving VO2MAX, lactate threshold, and running economy. However, the concept of the 'endorphin rush' at higher aerobic intensities and the evidence for depression reduction suggest that a mixed-intensity approach—combining Zone 2 base work with periodic higher-intensity sessions—produces both the metabolic and neurobiological benefits [55,56].
Anaerobic Exercise
Anaerobic exercise operates beyond the anaerobic threshold, relying on the phosphocreatine system and anaerobic glycolysis for ATP regeneration. This includes sprinting (100m, 200m, 400m events), explosive plyometric movements, maximal-effort Olympic weightlifting, and very heavy resistance training (1-5 repetition maximum). Anaerobic exercise is characterised by rapid ATP depletion, lactate accumulation, hydrogen ion production (causing the sensation of 'burn'), and rapid fatigue limiting bout duration to seconds to 60-90 seconds [57,58,59].
The physiological adaptations to anaerobic training are distinct from aerobic training: increased PCr stores and recovery rate, upregulation of anaerobic glycolytic enzymes (phosphofructokinase, lactate dehydrogenase), increased buffering capacity (elevated muscle carnosine, improved bicarbonate transport), enhanced neuromuscular recruitment efficiency, and increases in fast-twitch fibre cross-sectional area. These adaptations improve power output, rate of force development, and anaerobic capacity [60,61,62].
High-Intensity Interval Training (HIIT)
HIIT alternates brief bouts of near-maximal or maximal intensity exercise with active or passive recovery periods. The defining variables are work interval duration (typically 15 seconds to 4 minutes), recovery duration, work-to-rest ratio, total number of intervals, and the intensity of both work and recovery periods. Different HIIT protocols produce substantially different physiological outcomes [63,64,65].
Sprint Interval Training (SIT) employs very short work intervals (6-30 seconds) at all-out effort with extended recovery (60-300 seconds). The Wingate protocol (30-second all-out sprint on a cycle ergometer) is the most studied SIT format, producing acute increases in growth hormone (500-3000%), catecholamine concentrations, and post-exercise oxygen consumption. Chronic SIT adaptation produces improvements in anaerobic power, PCr resynthesis rate, and—surprisingly—aerobic capacity improvements comparable to moderate continuous training in far less total exercise time [66,67,68].
Aerobic Interval Training (AIT), typified by protocols such as the Norwegian 4x4 (4 minutes at 85-95% max HR, 3-minute active recovery, repeated 4 times), targets the upper aerobic system. AIT produces superior VO2MAX improvements compared to continuous moderate-intensity training of equivalent duration, driven by higher total time spent at high oxygen consumption rates. The high-intensity work intervals recruit both Type I and Type II fibres, stimulating a broader adaptive response [69,70,71].
The time-efficiency argument for HIIT is well-established: 20-30 minutes of HIIT produces metabolic adaptations comparable to 40-60 minutes of continuous moderate exercise. However, the recovery demands are proportionally greater—HIIT sessions require 24-48 hours of recovery before repetition, and the total weekly volume must be carefully managed to avoid overreaching. HIIT is not appropriate as the sole training modality; it functions optimally as a complement to aerobic base training [72,73].
High-Intensity Resistance Training (HIRT)
HIRT encompasses resistance training performed at high relative intensities (typically 70-100% of 1RM), low repetition ranges (1-6 repetitions), and with emphasis on progressive overload—the systematic increase in training stimulus over time through increased load, volume, or both. HIRT is the primary stimulus for skeletal muscle hypertrophy, strength, and neural adaptation [74,75,76].
The hypertrophy response to resistance training is driven by three primary mechanisms: mechanical tension (the primary stimulus—resistance exercise at loads exceeding approximately 60% of 1RM activates mechanotransduction pathways including mTORC1), metabolic stress (accumulation of metabolites including lactate and hydrogen ions, which stimulate growth hormone release and activate satellite cells), and muscle damage (eccentric-phase-induced microtrauma activating inflammatory repair cascades involving satellite cell proliferation and protein synthesis via IGF-1 and myostatin inhibition) [77,78,79].
Progressive overload is the fundamental principle of HIRT adaptation. The muscle adapts to any given load within 2-4 weeks (reaching a new steady state), necessitating progressive increases in either load, repetitions, sets, or frequency to maintain the adaptive stimulus. The most evidence-supported progression models include linear periodisation (increasing load each session—appropriate for beginners), undulating periodisation (varying load and rep range across weekly or daily cycles—appropriate for intermediate lifters), and block periodisation (dedicated training blocks emphasising specific adaptations—appropriate for advanced athletes) [80,81,82].
Table 1: Skeletal Muscle Fibre Type Comparison
| Property | Type I (Slow-Twitch) | Type IIa (Fast Oxidative) | Type IIx (Fast Glycolytic) |
|---|---|---|---|
| Myosin Heavy Chain | MHC-I | MHC-IIa | MHC-IIx |
| Contraction Speed | Slow (50-100 ms) | Fast (30-50 ms) | Very Fast (<30 ms) |
| Force Production | Low-Moderate | Moderate-High | Very High |
| Fatigue Resistance | Very High | Moderate | Low |
| Mitochondrial Density | Very High | Moderate-High | Low |
| Primary Fuel | Fatty acids + glucose (oxidative) | Glucose (glycolytic-oxidative) | Glucose + PCr (anaerobic) |
| Capillary Density | Very High | Moderate | Low |
| Relative Abundance | 40-60% (varies by individual) | 20-35% | 5-20% |
| Primary Exercise Recruited | Walking, jogging, posture, Zone 2 | Moderate resistance, tempo runs | Sprinting, heavy lifts, plyometrics |
| Hypertrophy Potential | Moderate | High | Very High |
Table 2: The Three ATP Regeneration Systems
| Parameter | ATP-PC (Phosphocreatine) | Anaerobic Glycolysis | Aerobic Oxidation |
|---|---|---|---|
| Oxygen Required | No | No | Yes |
| Time to Peak Output | Immediate (0-2 sec) | 5-15 seconds | 2-3 minutes |
| Duration of Dominance | 0-10 seconds | 10 sec - 2 min | >2 minutes |
| ATP Yield per Substrate | 1 ATP per PCr | 2 ATP per glucose | 30-32 ATP per glucose |
| Rate of ATP Production | Very High (fastest) | High | Moderate (slowest) |
| Primary Substrate | Phosphocreatine | Muscle glycogen | Glycogen, fat, amino acids |
| Byproducts | Creatine + Pi | Lactate + H+ | CO2 + H2O |
| Recovery Time | 30 sec (50%) / 5 min (95%) | Minutes (lactate clearance) | Hours (glycogen resynthesis) |
| Key Enzymes | Creatine kinase | PFK, LDH | Pyruvate dehydrogenase, SDH |
| Example Activity | 100m sprint, jump | 400m run, heavy sets | Cycling, marathon, swimming |
Table 3: Exercise Modality Comparison
| Parameter | Aerobic (Zone 2) | Anaerobic | HIIT | HIRT |
|---|---|---|---|---|
| Intensity (% Max HR) | 60-70% | 90-100% | 85-100% (work) | N/A (load-based) |
| Duration per Session | 30-90 min | 10-30 min total | 15-30 min total | 30-75 min |
| Primary Energy System | Aerobic oxidation | ATP-PC + Anaerobic glycolysis | All three (mixed) | ATP-PC + Anaerobic glycolysis |
| Primary Fibre Recruited | Type I dominant | Type IIx dominant | Type I, IIa, IIx | Type IIa, IIx (load-dependent) |
| VO2MAX Improvement | High (Grade A) | Moderate | High (Grade A) | Low-Moderate |
| Hypertrophy Stimulus | Minimal | Low | Low-Moderate | High (Grade A) |
| Fat Loss (acute) | Moderate (during) | High (EPOC) | Very High (EPOC) | Moderate (EPOC) |
| BDNF Release | High | Moderate | Very High | Moderate |
| Recovery Demand | Low | High | Very High | High |
| Weekly Frequency | 3-5x | 2-3x | 2-3x | 2-4x (per muscle group) |
| Evidence Grade (Longevity) | A | B | A-B | A |
III. METABOLIC RESPONSES TO EXERCISE
Substrate Utilisation and the Respiratory Exchange Ratio
The respiratory exchange ratio (RER = VCO2 produced / VO2 consumed) provides a non-invasive index of substrate utilisation during exercise. An RER of 0.7 indicates pure fat oxidation (C55H104O6 + 78O2 = 55CO2 + 52H2O); an RER of 1.0 indicates pure carbohydrate oxidation (C6H12O6 + 6O2 = 6CO2 + 6H2O). During moderate aerobic exercise, RER typically ranges 0.80-0.90, reflecting a mixed fuel utilisation. During maximal effort, RER exceeds 1.0 (indicating CO2 production from bicarbonate buffering of excess H+ from anaerobic glycolysis—not actual substrate oxidation above 1.0) [83,84,85].
Exercise intensity is the strongest determinant of the fat-to-carbohydrate utilisation ratio. At low intensities (Zone 1-2), fatty acid oxidation provides 60-90% of ATP; at moderate intensities (Zone 3), this shifts to approximately 50:50; at high intensities (Zone 4-5), carbohydrate oxidation dominates (70-90% of ATP). This intensity-dependent shift occurs because the rate of fatty acid transport into mitochondria (via carnitine palmitoyltransferase I, CPT-I) cannot match the ATP demand at high workloads—glucose, stored as glycogen adjacent to the mitochondria, can be mobilised and metabolised far more rapidly [86,87,88].
Training status profoundly alters substrate utilisation at equivalent absolute workloads. Endurance-trained individuals exhibit greater fat oxidation at any given exercise intensity compared to untrained individuals, driven by: increased mitochondrial density and oxidative enzyme activity, upregulated CPT-I activity, enhanced adipose tissue lipolysis and free fatty acid delivery, increased type I fibre proportion, and improved insulin sensitivity facilitating glucose sparing. This metabolic flexibility is a hallmark of fitness [89,90].
Excess Post-Exercise Oxygen Consumption (EPOC)
EPOC represents the elevated metabolic rate persisting after exercise cessation, during which oxygen consumption remains above resting levels. The magnitude and duration of EPOC are determined by exercise intensity, duration, and type. EPOC serves several metabolic functions: restoring depleted PCr stores (occurring within the first 2-3 minutes), clearing accumulated lactate (which is oxidised in the liver and heart or converted back to glucose via gluconeogenesis—the Cori cycle), restoring oxygen stores in haemoglobin and myoglobin, thermoregulation (rewarming the body), and repairing exercise-induced microtrauma [91,92,93].
High-intensity exercise produces substantially greater EPOC than low-intensity exercise of equivalent duration. A single HIIT session can elevate metabolic rate by 15-25% above resting for 12-24 hours post-exercise, compared to 5-10% elevation for 4-6 hours after steady-state moderate exercise. HIRT also produces significant EPOC, particularly when performed to muscular failure with heavy loads. This elevated post-exercise metabolism represents a mechanism through which time-efficient high-intensity protocols achieve equivalent or superior fat loss to longer-duration moderate exercise [94,95].
Hormonal Cascades: The Exercise Endocrine Response
Exercise is a powerful endocrine stimulus, triggering acute hormonal changes that orchestrate recovery, adaptation, and systemic health benefits. Catecholamines (epinephrine, norepinephrine) rise rapidly during exercise, proportional to intensity, stimulating lipolysis, glycogenolysis, and cardiovascular output. Cortisol rises in proportion to exercise duration and intensity, peaking at 20-40 minutes into high-intensity exercise; its role is permissive—facilitating substrate mobilisation and anti-inflammatory resolution—but chronically elevated cortisol (from excessive training without recovery) is immunosuppressive and catabolic [96,97,98].
Growth hormone (GH) release during exercise is intense but brief: a single bout of high-intensity exercise can produce GH elevations 500-3000% above baseline, with the magnitude driven primarily by intensity and the duration of exercise at that intensity. Post-exercise GH promotes fat oxidation, stimulates lipolysis, and contributes to muscle repair. However, acute exercise GH release does not reliably translate to chronic muscle growth—the sustained anabolic environment requires progressive resistance training stimulus combined with adequate protein intake [99,100].
Testosterone undergoes acute increases during resistance exercise (particularly heavy compound movements), driven by hemoconcentration and Leydig cell stimulation. The testosterone-to-cortisol ratio is used as an index of hormonal recovery status: a ratio above 0.2 mg/dL suggests an anabolic hormonal environment, while values below indicate excessive recovery demand. Training programmes should be periodised to maintain favourable testosterone-to-cortisol ratios over time [101,102].
GLUT4 Translocation: Insulin-Independent Glucose Uptake
One of the most physiologically significant acute effects of exercise is the translocation of GLUT4 glucose transporters to the skeletal muscle cell membrane, a process that occurs independently of insulin signalling. During exercise, muscle contraction activates AMPK (AMP-activated protein kinase) and a separate Akt-independent pathway that triggers GLUT4-containing vesicles to fuse with the sarcolemma, increasing glucose uptake 7-20 fold. This mechanism is preserved even in insulin-resistant states, meaning exercise remains an effective glucose-lowering intervention in type 2 diabetes regardless of insulin resistance severity [103,104,105].
The GLUT4 translocation response to exercise persists for approximately 30-60 minutes post-exercise, after which insulin becomes the primary driver of glucose uptake. This creates a critical window for post-exercise carbohydrate and protein intake to replenish glycogen stores and stimulate muscle protein synthesis. Chronic exercise training upregulates GLUT4 expression in muscle, increasing basal glucose uptake capacity and improving whole-body insulin sensitivity—a Grade A intervention for type 2 diabetes prevention [106,107].
Mitochondrial Biogenesis and PGC-1alpha
Mitochondrial biogenesis—the cellular process of generating new mitochondria—is a primary long-term adaptation to aerobic exercise and a central mechanism underlying exercise's longevity benefits. The master regulator of mitochondrial biogenesis is PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), a transcriptional coactivator that coordinates the expression of nuclear genes encoding mitochondrial proteins. Exercise activates PGC-1alpha through multiple upstream signals: AMPK activation (from elevated AMP/ATP ratio during exercise), calcium signalling via CaMKII, and p38 MAPK activation [108,109,110].
Increased mitochondrial density within skeletal muscle enhances oxygen extraction capacity, increases fatty acid oxidation rate, reduces lactate production at equivalent workloads, and improves exercise economy. Critically, mitochondrial function declines 30-50% with age—a decline that substantially contributes to age-related functional decline, metabolic dysfunction, and increased disease risk. Aerobic exercise is the most potent stimulus for reversing age-related mitochondrial decline, with Zone 2 training producing the strongest PGC-1alpha activation relative to sympathetic nervous system stress [111,112].
Table 4: Acute Hormonal Responses to Exercise
| Hormone | Acute Change | Peak Timing | Primary Trigger | Physiological Role |
|---|---|---|---|---|
| Epinephrine | 10-50x increase | During exercise | Sympathetic activation | Lipolysis, glycogenolysis, cardiac output |
| Norepinephrine | 5-20x increase | During exercise | Sympathetic activation | Vasoconstriction, substrate mobilisation |
| Cortisol | 2-5x increase | 20-40 min into exercise | ACTH/HPA axis | Substrate mobilisation, anti-inflammatory |
| Growth Hormone | 500-3000% increase | Immediately post-exercise | Intensity + pituitary | Fat oxidation, tissue repair, lipolysis |
| Testosterone | 10-40% increase | Immediately post-exercise | Hemoconcentration + Leydig | Muscle protein synthesis, recovery |
| Insulin | Acute decrease | During exercise | Catecholamine suppression | Reduced storage, fat mobilisation |
| IGF-1 | Moderate increase | 1-2 hours post-exercise | GH-liver axis | Muscle growth, tissue repair |
| Irisin | Significant increase | 30-60 min post-exercise | FNDC5 cleavage (myokine) | Browning of white fat, thermogenesis |
| BDNF | 2-3 fold increase | During/immediately post | Hippocampus + muscle | Neurogenesis, synaptic plasticity |
| IL-6 (myokine) | Acute increase | During exercise | Muscle contraction | Anti-inflammatory, glucose mobilisation |
- PHYSICAL HEALTH: SYSTEMS-LEVEL EFFECTS
Cardiovascular System
The cardiovascular benefits of regular exercise represent the strongest evidence base in all of preventive medicine—Grade A across multiple large randomised trials and prospective cohorts. Regular aerobic exercise reduces resting heart rate (by 5-15 bpm in trained individuals), lowers resting blood pressure (systolic by 5-10 mmHg, diastolic by 3-7 mmHg), reduces LDL cholesterol and triglycerides, increases HDL cholesterol, improves endothelial function through increased nitric oxide bioavailability, and reduces arterial stiffness as measured by pulse wave velocity [113,114,115].
Anatomical Heart Illustration
StockCake: https://stockcake.com/i/anatomical-heart-illustration_1399863_583492
The cardiac remodelling induced by endurance training—increased left ventricular cavity volume, increased stroke volume, increased cardiac output capacity—represents the most efficient cardiovascular phenotype for sustained oxygen delivery. VO2MAX (maximum oxygen uptake), the single best predictor of cardiovascular fitness and all-cause mortality, increases 10-20% in previously sedentary individuals within 3-6 months of regular aerobic training and can increase 20-40% or more over 1-2 years of structured endurance training. Each 1 MET increase in VO2MAX is associated with approximately 13% reduction in all-cause mortality and 15% reduction in cardiovascular mortality [116,117,118].
Musculoskeletal System
Bone density responds to mechanical loading according to Wolff's Law—bone remodels in response to the mechanical stresses placed upon it. Weight-bearing and resistance exercise stimulate osteoblast activity (bone formation) and suppress osteoclast activity (bone resorption), increasing bone mineral density (BMD), particularly in weight-bearing sites (lumbar spine, hip, femoral neck). The osteogenic stimulus requires ground reaction forces exceeding 2-3 times body weight—achievable through jogging, jumping, and resistance training but not through swimming or cycling [119,120,121].
Muscles in Motion
StockCake: https://stockcake.com/i/muscles-in-motion_1502270_1169942
Tendon adaptation to exercise follows a similar mechanical loading principle but with significantly longer adaptation timelines. Tendons increase collagen synthesis and cross-linking in response to eccentric loading (lengthening under tension), improving tensile strength and stiffness. This adaptation requires 6-12 weeks to manifest meaningfully—a critical consideration in training progression, as muscle strength gains outpace tendon adaptation, creating an injury risk window in rapid strength progressors [122,123].
Cartilage health is maintained through cyclic loading: exercise stimulates the movement of synovial fluid across the articular surface, delivering nutrients and removing waste products from chondrocytes (which lack direct blood supply). Moderate-impact exercise (walking, cycling, swimming) promotes cartilage health, while excessive high-impact repetitive loading without adequate recovery may accelerate cartilage degradation. The dose-response relationship is U-shaped—both inactivity and excessive impact loading impair cartilage [124,125].
Metabolic Health
Exercise improves insulin sensitivity through multiple mechanisms: acute GLUT4 translocation (described in Section III), chronic upregulation of GLUT4 expression, reduced hepatic glucose output, improved adipose tissue insulin signalling, and reduced systemic inflammation. The combination of aerobic and resistance training produces the greatest improvement in insulin sensitivity of any exercise modality—a Grade A intervention for type 2 diabetes prevention with effect sizes equivalent to the most effective pharmacological agents [126,127,128].
Body composition effects of exercise are driven by both fat oxidation during exercise (greater during low-intensity, prolonged aerobic exercise) and EPOC-mediated metabolic elevation (greater after high-intensity exercise). Resistance training uniquely preserves or increases lean mass during caloric deficit, making it essential in any fat-loss programme to prevent muscle wasting. The combination of resistance training with a moderate caloric deficit (300-500 kcal/day) and adequate protein intake (1.6-2.2g/kg lean mass) produces optimal body recomposition—reducing fat while maintaining or slightly increasing muscle mass [129,130].
Immune Function: The J-Curve
The relationship between exercise intensity and immune function follows a J-shaped curve. Sedentary individuals have elevated infection risk; moderate exercise reduces infection risk below the sedentary baseline (the bottom of the J); however, very high-intensity or high-volume exercise (particularly in competitive athletes without adequate recovery) transiently suppresses immune function, increasing upper respiratory tract infection risk for 12-72 hours post-exercise. This transient immunosuppression is mediated by cortisol-induced lymphocyte apoptosis and reduced mucosal IgA secretion [131,132,133].
The acute inflammatory response to exercise—characterised by an initial pro-inflammatory phase (IL-6, TNF-alpha release from damaged muscle) followed by a robust anti-inflammatory phase (IL-10, TGF-beta, anti-inflammatory IL-6 acting as a myokine)—represents a fundamental mechanism through which regular exercise reduces chronic disease risk. This exercise-induced anti-inflammatory cascade directly counteracts the chronic low-grade inflammation associated with obesity, metabolic syndrome, and cardiovascular disease [134,135].
Longevity Biomarkers
Exercise favourably modifies virtually every biomarker associated with biological aging. Telomere length—a marker of cellular aging—is longer in physically active individuals, with a meta-analysis of 21 studies demonstrating a correlation between physical activity and telomere length equivalent to 5-9 years of aging protection. Exercise reduces inflammatory markers (hs-CRP, IL-6, TNF-alpha), improves lipid profiles, reduces oxidative stress markers (8-OHdG, F2-isoprostanes), and favourably alters epigenetic markers including DNA methylation age—the most validated molecular clock of biological aging [136,137,138].
- MENTAL HEALTH: NEUROBIOLOGICAL MECHANISMS
BDNF and Neurogenesis
Brain-derived neurotrophic factor (BDNF) is the primary molecular mediator linking exercise to cognitive and mental health benefits. BDNF is a neurotrophin—a small protein that promotes the survival, differentiation, and maintenance of neurons—and its expression in the hippocampus (the brain region most critical for memory formation and most vulnerable to age-related atrophy) is upregulated 2-3 fold following a single bout of moderate-to-vigorous aerobic exercise [139,140,141].
The exercise-BDNF connection operates through multiple pathways. Contracting skeletal muscle produces irisin (cleaved from FNDC5), which crosses the blood-brain barrier and stimulates BDNF expression in the hippocampus. Exercise also increases cerebral blood flow, raises brain glucose utilisation, and upregulates BDNF transcription via CREB (cAMP response element-binding protein) activation. Chronically, regular aerobic exercise increases hippocampal volume by 1-2% per year—reversing the 1-2% annual volume loss associated with normal aging [142,143,144].
The cognitive consequences are measurable: a landmark RCT (Erickson et al., 2011) demonstrated that 12 months of aerobic exercise training in older adults produced significant hippocampal volume increases and corresponding improvements in spatial memory. Subsequent studies have extended these findings to executive function, processing speed, and working memory. The BDNF-neurogenesis-cognitive function axis represents the strongest evidence-based mechanism for exercise-induced cognitive protection [145,146].
Endorphins, Endocannabinoids, and Monoamine Neurotransmitters
The popular concept of the 'runner's high' was historically attributed to endorphin release—endogenous opioid peptides released during vigorous exercise. While exercise does increase circulating beta-endorphin (particularly during high-intensity exercise exceeding 70% VO2MAX), endorphins do not cross the blood-brain barrier efficiently, making their role in producing euphoric states uncertain [147,148].
The endocannabinoid system now offers a more compelling explanation. Exercise—particularly aerobic exercise at moderate-to-vigorous intensities—elevates circulating levels of anandamide and 2-AG (endocannabinoids), which do cross the blood-brain barrier and act on CB1 receptors in the limbic system to produce anxiolytic and euphoric effects. A 2021 study demonstrated that blocking endocannabinoid receptors abolished the exercise-induced mood improvement, while blocking opioid receptors did not—strongly implicating endocannabinoids over endorphins as the primary mediators of exercise-induced euphoria [149,150,151].
Monoamine neurotransmitters—serotonin, dopamine, and noradrenaline—are all elevated during and after exercise, with the magnitude dependent on exercise type and intensity. Acute exercise increases serotonin synthesis (via enhanced tryptophan uptake into the brain, driven by increased free fatty acid mobilisation competing for albumin-bound tryptophan transport) and dopamine release in the reward circuitry of the mesolimbic pathway. These changes underlie exercise's demonstrated efficacy for depression and reward motivation [152,153].
HPA Axis Regulation and Stress Resilience
Regular exercise trains the hypothalamic-pituitary-adrenal (HPA) axis in the same manner it trains the cardiovascular system: by repeatedly exposing it to controlled stress, it becomes more responsive (faster cortisol rise during acute stress) and more efficient at recovery (faster return to baseline via enhanced glucocorticoid receptor sensitivity and negative feedback). This 'stress inoculation' effect means that regularly exercising individuals exhibit a more controlled cortisol response to psychological and physiological stressors—lower peak cortisol, faster recovery, and reduced duration of HPA axis activation [154,155,156].
The anti-stress benefits of exercise extend to the autonomic nervous system: regular exercise increases cardiac vagal tone (measured via heart rate variability), shifting autonomic balance toward parasympathetic dominance at rest. Increased HRV is independently associated with reduced cardiovascular risk, better emotional regulation, and increased resilience to psychosocial stress. This autonomic adaptation is particularly pronounced with aerobic training at moderate intensities [157,158].
Depression and Anxiety: The Evidence Base
The evidence for exercise as an intervention for depression has reached sufficient strength to warrant inclusion in clinical practice guidelines in multiple countries. A meta-analysis of 33 randomised controlled trials (Schuch et al., 2016) demonstrated that exercise produced a large effect size for depression reduction (SMD = -0.66), comparable to antidepressant medication. Aerobic exercise at moderate-to-vigorous intensity, performed 3-5 times per week for 8-12 weeks, produced the most consistent antidepressant effects. Resistance training also demonstrated significant antidepressant effects, though with a smaller effect size [159,160,161].
For anxiety disorders, the evidence is moderately strong (Grade B). Aerobic exercise reduces both trait and state anxiety, with effect sizes comparable to anxiolytic medication in chronic anxiety conditions. The anxiolytic mechanism involves reduced sympathetic nervous system reactivity, elevated endocannabinoid tone, and increased GABA-ergic activity in the amygdala following regular exercise training [162,163].
Cognitive Function and Executive Function
Exercise improves cognitive function across multiple domains: attention, processing speed, working memory, and executive function (planning, decision-making, cognitive flexibility). The acute effect—measurable within 20-30 minutes of a single moderate exercise bout—is driven by catecholamine release enhancing prefrontal cortical function. The chronic effect—accumulating over weeks to months of regular training—is driven by BDNF-mediated neuroplasticity, increased cerebral blood flow, and reduced neuroinflammation [164,165,166].
Particularly compelling is the evidence for exercise in neurodegenerative disease prevention. Physical inactivity is an independent risk factor for Alzheimer's disease, and regular aerobic exercise reduces Alzheimer's risk by 30-40% in population studies. Animal models demonstrate that exercise reduces amyloid-beta plaque burden, tau phosphorylation, and neuroinflammation—the three hallmark pathologies of Alzheimer's disease. While the evidence in humans remains largely epidemiological, the mechanistic evidence is sufficiently strong to position exercise as a primary preventive intervention for cognitive decline [167,168].
- EXERCISE REGIMES: BEGINNER, INTERMEDIATE, AND ADVANCED
Exercise prescription must account for current fitness level, available time, training goals, and recovery capacity. This section presents structured protocols across three fitness levels for five primary objectives: cardiovascular fitness, fat loss, muscle hypertrophy, strength, and longevity optimisation. Each protocol integrates the four exercise modalities analysed in Section II within a periodised framework [169,170,171].
Periodisation Principles
Periodisation is the systematic variation of training stimulus over defined time periods to optimise adaptation, prevent staleness, and manage recovery demand. Macrocycles (12-16 weeks) are divided into mesocycles (3-5 weeks) which contain microcycles (individual weeks). Within each mesocycle, progressive overload is applied systematically. The final week of each mesocycle is typically a deload week—reducing volume by 40-50% to allow accumulated recovery debt to be repaid. This structure applies across all fitness levels, though the specific parameters differ [172,173].
RPE (Rate of Perceived Exertion) on the Borg 6-20 scale or the modified 0-10 RPE scale provides a practical method for prescribing relative intensity in resistance training. An RPE of 8 means 2 repetitions in reserve (RIR = 2)—the lifter could perform 2 additional repetitions before failure. Training at RPE 7-9 (RIR 1-3) provides sufficient mechanical tension for hypertrophy and strength stimulus while maintaining technical proficiency and reducing injury risk [174,175].
Beginner Protocols
Beginners (defined as individuals with less than 6 months of consistent training experience or returning after prolonged detraining) respond to the greatest range of stimuli—a phenomenon termed 'novice gains.' Simple, compound-movement-dominant programmes with linear progression (adding small amounts of weight each session) produce rapid strength and hypertrophy gains without the complexity of advanced periodisation. Recovery demands are moderate, and training frequency of 3 days per week is sufficient to produce significant adaptations [176,177].
For beginners, the priority hierarchy is: (1) establish movement competency in fundamental patterns (squat, hinge, push, pull, carry), (2) build an aerobic base through regular Zone 2 activity, (3) progressively increase resistance training volume and load. Technique should never be sacrificed for load—this is the period with the highest injury risk if progression is too aggressive [178,179].
Intermediate Protocols
Intermediate trainees (6 months to 3 years of consistent training) have exhausted linear progression and require undulating periodisation—varying intensity, volume, and movement selection across the training week or across weeks within a mesocycle. Training frequency increases to 4-5 days per week, and exercise selection diversifies to include accessory movements targeting specific weak points. Recovery management becomes more important: sleep optimisation, nutrition timing, and deload scheduling are no longer optional [180,181,182].
Intermediate athletes benefit from incorporating all four exercise modalities into their weekly structure: 2-3 aerobic sessions (Zone 2 base), 1-2 HIIT or sprint sessions, 3-4 resistance sessions (combining hypertrophy and strength emphasis in undulating fashion), and dedicated mobility/flexibility work. This concurrent training approach produces balanced fitness development and cross-adaptation benefits [183,184].
Advanced Protocols
Advanced trainees (3+ years of consistent, progressive training) require block periodisation—dedicated mesocycles emphasising specific adaptations (e.g., 4 weeks hypertrophy-focused followed by 3 weeks strength-focused followed by 2 weeks power-focused). Training volume is high (20-30+ sets per muscle group per week for hypertrophy), and recovery management becomes the primary limiting factor for progression. Exercise selection is highly individualised based on biomechanical assessment, injury history, and specific competition or fitness goals [185,186,187].
Advanced individuals should integrate periodised aerobic work alongside resistance training, respecting the interference effect—concurrent high-volume aerobic and resistance training can attenuate hypertrophy and strength gains if not carefully periodised. Separating aerobic and resistance sessions by 6+ hours, or placing them on different days, minimises interference. Advanced longevity-oriented training emphasises maintaining VO2MAX (which declines 7-15% per decade with age) alongside grip strength and functional capacity [188,189].
Table 5: Beginner Weekly Training Programme
| Day | Type | Exercise | Sets x Reps | Rest | Notes |
|---|---|---|---|---|---|
| Monday | HIRT (Full Body) | Barbell Squat | 3 x 8-10 | 90 sec | RPE 7 — 2-3 RIR |
| Dumbbell Bench Press | 3 x 8-10 | 60 sec | RPE 7 | ||
| Bent-Over Dumbbell Row | 3 x 8-10 | 60 sec | RPE 7 | ||
| Romanian Deadlift | 3 x 10-12 | 90 sec | RPE 7 | ||
| Overhead Dumbbell Press | 2 x 10-12 | 60 sec | RPE 7 | ||
| Tuesday | Aerobic (Zone 2) | Brisk Walking / Cycling | 1 x 30-45 min | N/A | HR 120-140 bpm |
| Wednesday | Rest / Mobility | Stretching + Foam Rolling | 15-20 min | N/A | Focus on hips, shoulders, thoracic |
| Thursday | HIRT (Full Body) | Deadlift (conventional or trap bar) | 3 x 5-6 | 120 sec | RPE 7-8 |
| Incline Dumbbell Press | 3 x 8-10 | 60 sec | RPE 7 | ||
| Cable or Band Pull-Aparts | 3 x 12-15 | 45 sec | Posture focus | ||
| Goblet Squat | 2 x 12 | 60 sec | Depth priority | ||
| Plank Hold | 3 x 30-60 sec | 30 sec | Core stability | ||
| Friday | Aerobic (Zone 2) | Jogging / Swimming | 1 x 30-40 min | N/A | HR 120-140 bpm |
| Saturday | HIIT (Light) | Bodyweight Circuit: Burpees / Squat Jumps / Mountain Climbers / Rest | 4 rounds | 20 sec on / 40 sec off | Total 12-15 min |
| Sunday | Active Recovery | Walk 20-30 min | 1 x 20-30 min | N/A | Gentle movement only |
Table 6: Intermediate Weekly Training Programme
| Day | Type | Exercise | Sets x Reps | RPE | Target |
|---|---|---|---|---|---|
| Mon | HIRT Upper (Hyp/Str) | Barbell Bench Press | 4 x 6-10 | 8 | Chest — primary |
| Weighted Pull-Ups | 4 x 4-8 | 8-9 | Back — primary | ||
| Overhead Press | 3 x 6-8 | 8 | Shoulders — primary | ||
| Barbell Rows | 3 x 6-8 | 8 | Mid-back | ||
| Tricep Dips + Bicep Curls | 3 x 8-12 each | 7 | Accessory | ||
| Tue | Aerobic Zone 2 | Steady-State Cycling / Run | 45-60 min | N/A | HR 120-145 bpm |
| Wed | HIRT Lower (Hyp/Str) | Barbell Back Squat | 4 x 5-8 | 8-9 | Quads/Glutes — primary |
| Romanian Deadlift | 4 x 6-8 | 8 | Hamstrings/Glutes | ||
| Bulgarian Split Squat | 3 x 8-10 each leg | 7-8 | Unilateral balance | ||
| Leg Press | 3 x 10-12 | 7 | Volume accumulation | ||
| Calf Raises + Leg Curls | 3 x 12-15 each | 7 | Accessory | ||
| Thu | HIIT | 4x4 Protocol: 4 min on (85-95% HR) / 3 min walk x4 | 4 intervals | 9-10 | VO2MAX stimulus |
| Fri | HIRT Upper (Str/Hyp) | Incline Press / Lat Pulldown / Lateral Raises / Face Pulls | 3-4 sets each | 7-8 | Complementary upper |
| Sat | Aerobic Zone 2 | Run / Row / Swim | 45-60 min | N/A | HR 120-145 bpm |
| Sun | Active Recovery | Yoga / Walk / Mobility | 30-45 min | N/A | Parasympathetic focus |
Table 7: Advanced Weekly Training Programme
| Day | Type | Focus | Volume | Intensity | Key Prescription |
|---|---|---|---|---|---|
| Mon | HIRT — Push | Chest / Shoulders / Triceps | 20-24 sets total | RPE 7-9 | Bench Press 5x3-6 @RPE9 + 3x6-8 @RPE7; OHP 4x4-6; Dips, Flyes, Laterals, Triceps |
| Tue | HIRT — Pull | Back / Biceps / Rear Delts | 20-24 sets total | RPE 7-9 | Deadlift 3x2-4 @RPE9; Weighted Pull-Ups 4x3-6; Rows (barbell + cable); Curl variations; Face pulls |
| Wed | Aerobic Zone 2 + Mobility | Endurance base + flexibility | 45-60 min aerobic | HR 120-150 bpm | Run or Cycle Zone 2 + 15 min mobility. Separate from resistance by 6+ hours if same day. |
| Thu | HIRT — Legs | Quads / Hamstrings / Glutes / Calves | 22-28 sets total | RPE 8-9 | Squat 5x2-4 @RPE9; Front Squat 3x4-6; RDL 4x4-6; Leg Press; Split Squats; Leg Curls; Calves |
| Fri | HIIT + Sprint Work | Anaerobic power + VO2MAX | 20-25 min total | Max effort | 6x30s Wingate with 4 min recovery OR 5x400m sprint at 95% with 2 min walk recovery |
| Sat | HIRT — Upper (Complementary) | Weak points + accessory volume | 16-20 sets total | RPE 7-8 | Incline Press 4x6-8; Pulldowns; Lateral Raises; Rear Delt flies; Brachialis; Core (weighted) |
| Sun | Active Recovery | Parasympathetic restoration | 30-45 min | Very low | Long walk / gentle yoga / sauna (if available). HRV monitoring to confirm recovery. |
VII. MEASURING FITNESS: COMPREHENSIVE ASSESSMENT TECHNOLOGIES
Objective fitness assessment is essential for establishing baseline status, tracking progress, identifying weaknesses, and guiding programme modification. This section examines the full spectrum of assessment technologies—from gold-standard laboratory methods through emerging consumer technologies—evaluating each on the basis of accuracy, reproducibility, clinical utility, and practical accessibility [190,191,192].
Body Composition: DEXA, BIA, and Skinfolds
Dual-energy X-ray absorptiometry (DEXA) is the gold standard for body composition assessment. DEXA exposes the body to two X-ray beams of different energies (typically 38 and 70 keV), and differential attenuation through bone, fat, and lean tissue allows mathematical calculation of bone mineral density, lean mass, and fat mass with high precision (coefficient of variation 1-2%) and accuracy. A full-body DEXA scan takes 10-15 minutes, requires no preparation beyond standard fasting protocols, and provides regional body composition data (arms, legs, torso, head) in addition to total-body values. DEXA is the reference method against which all other body composition techniques are validated [193,194,195].
Bioelectrical impedance analysis (BIA) passes a small alternating current through the body and measures the impedance (resistance and reactance) of tissues to current flow. Fat tissue is a poor conductor (high impedance); lean tissue is a good conductor (low impedance) due to its water and electrolyte content. Modern multi-frequency, segmental BIA devices (e.g., InBody, Tanita) provide body composition estimates with accuracy within 2-4% of DEXA in controlled conditions. However, BIA is sensitive to hydration status, recent exercise, food intake, and body position—requiring strict standardisation protocols for serial measurements [196,197].
Skinfold callipers measure subcutaneous fat thickness at standardised anatomical sites (typically 3, 7, or 10 sites), and prediction equations (Jackson-Pollock, Durnin-Womersley) convert these measurements to estimated body fat percentage. Accuracy depends heavily on assessor experience—inter-rater reliability is poor without training. Skinfolds underestimate body fat in obese individuals and miss visceral (abdominal organ-surrounding) fat entirely. Despite these limitations, serial skinfold measurements by a consistent assessor provide useful trend data for monitoring fat loss [198,199].
Imaging: MRI and CT
Magnetic resonance imaging (MRI) provides the most detailed assessment of musculoskeletal anatomy available without ionising radiation. Muscle cross-sectional area (CSA) measured via MRI is considered the gold standard for hypertrophy assessment—more precise than circumference measurements or DEXA regional lean mass estimates. MRI can also identify specific muscle pathology (tears, fatty infiltration, inflammation) and assess deep tissue structures invisible to external measurement. Limitations include cost (£500-1500 per scan), time (30-60 minutes in the scanner), limited availability, and the need for specialised analysis software [200,201].
Computed tomography (CT) scanning provides cross-sectional imaging with ionising radiation. CT is particularly valuable for quantifying visceral adipose tissue (VAT)—the metabolically dangerous fat depot surrounding abdominal organs that is invisible to DEXA or skinfolds. A single axial CT slice at L4-L5 can distinguish visceral from subcutaneous abdominal fat with high precision. VAT area exceeding 100 cm2 is defined as visceral obesity and is strongly associated with insulin resistance, cardiovascular risk, and hepatic steatosis—independent of total body fat percentage [202,203].
Cardiovascular Fitness: VO2MAX and Lactate Threshold
VO2MAX (maximal oxygen uptake) is the gold standard measure of cardiovascular fitness and the single best laboratory predictor of all-cause mortality. Measured during a graded exercise test to exhaustion on a treadmill or cycle ergometer with continuous expired gas analysis, VO2MAX represents the maximal rate at which the body can deliver and utilise oxygen. Values are expressed in mL O2/kg/min and range from approximately 25-30 mL/kg/min in sedentary untrained adults to 60-80+ mL/kg/min in elite endurance athletes. The test requires maximal effort and experienced supervision [204,205,206].
Lactate threshold testing involves blood lactate sampling (via fingertip or earlobe) at regular intervals during a graded exercise test. The onset of blood lactate accumulation (OBLA) or ventilatory threshold 2 (VT2) identifies the exercise intensity at which anaerobic glycolysis begins contributing significantly to ATP supply—the practical upper limit of sustainable aerobic exercise. Training at or just below this threshold (the 'sweet spot' of Zone 3-4) produces the greatest improvement in lactate threshold, running economy, and endurance performance. Serial lactate threshold testing (every 4-6 weeks) provides objective evidence of aerobic adaptation [207,208].
Field-based VO2MAX estimation methods include the Cooper 12-minute run test (distance covered correlates with VO2MAX), the Yo-Yo intermittent recovery test, and smartphone-based algorithms using heart rate and GPS data during outdoor running. These estimation methods have correlations of 0.85-0.95 with laboratory-measured VO2MAX but carry a standard error of 3-5 mL/kg/min—adequate for population-level tracking but insufficient for precise clinical assessment [209,210].
Neurological and Movement Assessment: Gait Analysis and EMG
Gait analysis quantifies the biomechanics of walking and running using instrumented systems: force plates measure ground reaction forces (GRF) during each stance phase; motion capture cameras (using reflective markers or markerless systems based on computer vision) track joint angles and segment velocities in three dimensions; and instrumented insoles measure plantar pressure distribution. Modern gait labs can identify asymmetries in stride length, ground contact time, vertical oscillation, and joint kinematics that are invisible to visual assessment [211,212,213].
Consumer-grade gait analysis has emerged through smartphone apps and wearable inertial measurement units (IMUs). Devices such as RunScribe, Garmin's running dynamics, and Apple Watch's stride metrics use accelerometers and gyroscopes to estimate gait parameters including ground contact time, vertical oscillation, stride length, and cadence. While less accurate than laboratory gold standards, these tools provide valuable longitudinal trend data for runners monitoring form and injury risk [214,215].
Electromyography (EMG) measures the electrical activity of muscle fibres during contraction via surface electrodes placed over the muscle belly. EMG provides information on which muscles are active during a given movement, the relative intensity of activation, and the temporal pattern of recruitment. In exercise science, EMG is used to compare muscle activation patterns across exercise variations (e.g., which squat variant maximises quadriceps activation), identify compensatory movement patterns, and assess neuromuscular fatigue during exercise sets [216,217].
Cardiac Assessment: ECG and Echocardiography
Electrocardiography (ECG) records the electrical activity of the heart via surface electrodes, producing a characteristic waveform (P wave: atrial depolarisation; QRS complex: ventricular depolarisation; T wave: ventricular repolarisation). A resting 12-lead ECG can identify arrhythmias, conduction abnormalities, evidence of previous myocardial infarction, and left ventricular hypertrophy. Exercise ECG (stress testing) reveals ischaemic changes, arrhythmias, and blood pressure responses that are only provoked by the haemodynamic demands of exercise [218,219].
Echocardiography uses ultrasound to image cardiac structure and function in real time. It can measure wall thickness, chamber dimensions, ejection fraction, valve function, and diastolic filling patterns—all relevant to assessing the cardiac adaptations to training (the 'athlete's heart'). Strain echocardiography (speckle tracking) provides quantitative assessment of myocardial deformation, offering earlier detection of cardiac dysfunction than conventional measures. Athletes with resting heart rates below 50 bpm or ECG abnormalities should be evaluated echocardiographically to distinguish physiological athletic heart remodelling from pathological cardiomyopathy [220,221].
Autonomic Nervous System: Heart Rate Variability
Heart rate variability (HRV) quantifies the beat-to-beat variation in cardiac interbeat intervals (RR intervals) and serves as a non-invasive window into autonomic nervous system function. High HRV at rest reflects dominant parasympathetic (vagal) tone—an indicator of cardiovascular fitness, stress resilience, and recovery status. Low HRV indicates sympathetic dominance, associated with physical or psychological stress, overtraining, illness, and cardiovascular risk [222,223,224].
HRV is measured using time-domain metrics (RMSSD—root mean square of successive differences, most responsive to vagal activity and preferred for short-duration recordings of 1-5 minutes) or frequency-domain metrics (high-frequency power representing parasympathetic activity; low-frequency power representing mixed sympathetic/parasympathetic). Modern consumer devices (Apple Watch, Garmin, Whoop, Oura Ring) provide daily HRV estimates using photoplethysmography (PPG) during sleep. While PPG-derived HRV is less accurate than ECG-derived measurements, the trend data across weeks is clinically useful for monitoring recovery status and training adaptation [225,226].
Functional Strength: Grip Strength and Dynamometry
Handgrip strength—measured using a calibrated hand dynamometer—is one of the most robust predictors of all-cause mortality, cardiovascular disease, and functional capacity in aging populations. A landmark study (Kawakami et al.) demonstrated that grip strength in middle age predicted mortality 22 years later independent of body composition, BMI, or conventional risk factors. Testing involves maximum voluntary contraction of the dominant hand (or both hands), repeated 3 times with 60 seconds rest, and the highest value is recorded [227,228,229].
Isokinetic dynamometry measures muscle force output through a range of motion at a controlled angular velocity, providing torque values that are independent of movement speed and lever arm length. This is particularly valuable for assessing bilateral strength asymmetries (a hamstring-to-quadriceps ratio below 0.6 is associated with anterior cruciate ligament injury risk), tracking rehabilitation progression, and identifying specific muscular weaknesses [230,231].
Emerging Assessment Technologies
Continuous glucose monitoring (CGM)—devices such as FreeStyle Libre, Dexcom, and Abbott Libre—provide real-time interstitial glucose measurements every 5-15 minutes. In the context of exercise assessment, CGMs reveal glucose responses to different exercise modalities (resistance training produces more stable glucose than aerobic exercise), glycogen depletion patterns during endurance events, and post-exercise glucose regulation efficiency. CGM data can guide fuelling strategies and identify impaired glucose regulation invisible to fasting blood tests [232,233,234].
AI-driven motion capture systems (e.g., Dartfish, Hudl, Simi Motion) use computer vision algorithms to track joint positions from standard video footage without physical markers, reducing the barrier to biomechanical assessment. These systems can now identify injury risk patterns, movement inefficiencies, and compensatory patterns in real time during training—previously requiring expensive laboratory setups [235,236].
Epigenetic clocks—algorithms that estimate biological age from DNA methylation patterns in blood or saliva samples—represent perhaps the most compelling emerging biomarker of exercise adaptation. Companies such as TruAge and Foxo Technologies offer consumer-accessible epigenetic age testing. Studies demonstrate that physically active individuals have epigenetic ages 3-5 years younger than their chronological age, and that structured exercise programmes can produce measurable epigenetic age reduction within 6-12 months [237,238].
Blood biomarker panels combining inflammatory markers (hs-CRP, IL-6), metabolic markers (fasting insulin, triglycerides, HbA1c), hormonal markers (testosterone, IGF-1, cortisol), and cellular markers (telomere length, senescent cell counts) provide a comprehensive molecular snapshot of exercise adaptation. Companies such as Inside Tracker and Base provide algorithm-driven interpretations integrating these markers with lifestyle and genetic data to generate personalised exercise and recovery recommendations [239,240].
Table 8: Fitness Assessment Technology Comparison
| Technology | What It Measures | Accuracy | Cost | Accessibility | Clinical Utility |
|---|---|---|---|---|---|
| DEXA Scan | Body composition (bone, fat, lean mass) | Gold standard (1-2% CV) | £150-350 | Hospital / specialist clinic | Very High — reference method |
| MRI (Muscle) | Muscle CSA, pathology, hypertrophy | Gold standard for CSA | £500-1500 | Hospital only | Very High — research + clinical |
| CT (Visceral) | Visceral adipose tissue quantification | Gold standard for VAT | £200-500 | Hospital only | Very High — metabolic risk assessment |
| VO2MAX Test | Maximal aerobic capacity | Gold standard | £100-250 | Sports lab / cardiology | Very High — mortality predictor |
| Lactate Testing | Anaerobic threshold / training zones | High (blood-based) | £80-200 | Sports lab | High — training zone precision |
| Gait Analysis (Lab) | Running/walking biomechanics | Gold standard | £200-500 | Specialist sports lab | High — injury prevention |
| 12-Lead ECG | Cardiac electrical activity | Gold standard | £50-150 | GP / cardiology | Very High — cardiac screening |
| Echocardiography | Cardiac structure and function | Gold standard | £200-500 | Hospital / cardiology | Very High — athlete's heart assessment |
| HRV (ECG-based) | Autonomic nervous system function | Gold standard | £100-300 (chest strap) | Consumer device available | High — recovery and fitness monitoring |
| Grip Strength | Functional strength / mortality predictor | High (standardised) | £20-80 (dynamometer) | GP / gym / home | Very High — simple, predictive |
| CGM (Continuous Glucose) | Real-time glucose regulation | High (±15 mg/dL) | £50-80 per sensor | Pharmacy / online | Moderate-High — fuelling optimisation |
| Epigenetic Clock | Biological vs chronological age | Moderate (evolving) | £100-300 | Online testing service | Moderate — longitudinal tracking |
| AI Motion Capture | Joint kinematics from video | Moderate (improving) | Free - £50/month (apps) | Smartphone camera | Moderate — accessible biomechanics |
| Wearable HRV (PPG) | Estimated autonomic function | Moderate (vs ECG) | £200-500 (device) | Consumer wearable | Moderate — trend data useful |
| Blood Biomarker Panel | Inflammatory / metabolic / hormonal status | High (lab-based) | £150-500 | Online testing service | High — comprehensive molecular snapshot |
VIII. LATEST RESEARCH AND EMERGING CONCEPTS
Zone 2 Training and Mitochondrial Health
Zone 2 training—sustained exercise at 60-70% of maximum heart rate, in which fat oxidation dominates and the athlete can maintain a conversation—has undergone a significant renaissance in exercise science following the work of Alejandro Sabaté Pérez and others demonstrating its superiority for mitochondrial biogenesis. At Zone 2 intensity, PGC-1alpha activation is maximal relative to sympathetic nervous system stress, producing the greatest net stimulus for mitochondrial proliferation and function improvement. This is because higher intensities shift the balance toward sympathetic activation and cortisol release, which partially antagonise PGC-1alpha signalling [241,242,243].
A 2023 study by Huang et al. demonstrated that 12 weeks of Zone 2 cycling training produced a 25% increase in mitochondrial DNA copy number in skeletal muscle biopsies—a magnitude comparable to drug interventions targeting mitochondrial biogenesis. The same subjects showed improvements in fat oxidation rate, insulin sensitivity, and VO2MAX, while inflammatory markers declined. This positions Zone 2 training as a cornerstone of metabolic health and longevity exercise prescription [244,245].
Blood Flow Restriction Training
Blood flow restriction (BFR) training—also known as KAATSU training (from the Japanese developer)—involves applying external pressure cuffs to proximal muscle groups during low-load resistance exercise (typically 20-40% of 1RM), partially occluding venous return and creating a proximal pressure differential. This induces rapid metabolite accumulation (lactate, H+, inorganic phosphate) in the working muscle, triggering growth hormone release and activating mTORC1 through metabolic stress pathways—producing hypertrophy and strength gains at loads far below those traditionally considered necessary [246,247,248].
BFR training is particularly relevant for populations unable to tolerate heavy loads: elderly individuals, post-surgical rehabilitation patients, and individuals with joint pathology limiting loading capacity. A meta-analysis (Kaida et al., 2023) found that BFR training at 20-30% 1RM produced hypertrophy comparable to conventional training at 60-80% 1RM, with effect sizes of 0.5-0.8 (moderate-large). Safety data indicate that BFR is safe when cuff pressures are standardised (typically 40-60% of arterial occlusion pressure) and monitored [249,250].
Concurrent Training and the Interference Effect
Concurrent training—combining endurance and resis tance exercise within the same programme—is the most common training approach for general fitness, yet it produces a well-documented 'interference effect' whereby high-volume aerobic training attenuates hypertrophy and strength gains from resistance training, and high-volume resistance training reduces endurance adaptations. The mechanisms include: competition for shared molecular signalling pathways (AMPK activation from endurance work inhibits mTORC1, which is the primary signal for muscle protein synthesis from resistance training); glycogen depletion reducing resistance training performance; and neuromuscular fatigue from aerobic sessions impairing resistance training quality [251,252,253].
Recent research has identified optimal concurrent training strategies that minimise interference: separating aerobic and resistance sessions by at least 6 hours (or placing them on different days), prioritising resistance training when both are performed on the same day, maintaining aerobic volume at moderate levels (rather than excessive endurance training volumes), and using lower-impact aerobic modalities (cycling, swimming) that produce less neuromuscular fatigue than running [254,255].
Exercise Timing and Circadian Biology
The circadian system—the 24-hour biological clock regulated by the suprachiasmatic nucleus (SCN) of the hypothalamus—orchestrates rhythmic variation in core body temperature, hormonal secretion, cognitive function, and muscular performance throughout the day. Core body temperature peaks in the late afternoon (16:00-18:00), coinciding with peak neuromuscular performance: force production, reaction time, anaerobic power, and VO2MAX are all 3-8% higher in the late afternoon compared to the morning [256,257,258].
Morning exercise, while suboptimal for acute perform ance, may produce greater improvements in circadian rhythm stability—particularly for shift workers and individuals with circadian misalignment. A 2023 study demonstrated that consistent morning exercise (08:00) for 12 weeks produced significant phase advances in the circadian clock, improving sleep quality and reducing cardiometabolic markers more than equivalent evening exercise. The timing of exercise relative to the individual circadian phenotype (morning lark vs evening owl) also modulates training response, underscoring the importance of personalised exercise timing [259,260].
Exerkines: The Myokine Revolution
The concept of exerkines—signalling molecules released from muscle, adipose tissue, bone, and brain during exercise that mediate inter-organ communication—has transformed our understanding of exercise's systemic benefits. Myokines (muscle-derived) include IL-6 (acting as an anti-inflammatory myokine distinct from its pro-inflammatory role in infection), irisin (promoting browning of white adipose tissue and increasing thermogenesis), FNDC5, and cathepsin B (promoting neurogenesis). Batokines are released from brown adipose tissue activated during exercise; osteokines (including osteocalcin) are released from bone and enhance glucose metabolism and testosterone production [261,262,263].
Irisin has attracted particular attention: discovered in 2012 by Boström et al., irisin is cleaved from FNDC5 in contracting muscle, enters systemic circulation, crosses the blood-brain barrier to stimulate BDNF expression, acts on bone to stimulate osteoblast differentiation, and promotes browning of white adipocytes via UCP1 upregulation—increasing energy expenditure. While the magnitude of irisin's metabolic effects in humans remains debated, the exerkine paradigm fundamentally repositions exercise as an endocrine intervention rather than merely a mechanical one [264,265].
Genomic Personalisation of Exercise Prescription
Individual variation in exercise response is substantial—some individuals are 'high responders' to aerobic training (VO2MAX increases of 20-40%), while others are 'low responders' (increases of less than 5%) despite identical training programmes. Genetic polymorphisms in key exercise-response genes explain a portion of this variation [266,267,268].
The ACTN3 R577X polymorphism (alpha-actinin-3) determines fast-twitch fibre function: individuals homozygous for the R allele (RR genotype, approximately 30% of the population) have functional alpha-actinin-3 in their Type IIx fibres, conferring a 'power advantage' and greater hypertrophy response to resistance training. The XX genotype (approximately 18%) lacks functional alpha-actinin-3, producing a 'endurance advantage' with superior aerobic adaptation. The PPARGC1A (Gly482Ser) variant modulates PGC-1alpha activity, affecting mitochondrial biogenesis response to exercise. CYP1A2 genotype (affecting caffeine metabolism) determines the performance-enhancing effect of pre-exercise caffeine. Direct-to-consumer genomic testing (23andMe, Thorne Genetic) now provides actionable exercise-response genotyping, though integration into training prescription remains in its infancy [269,270].
- CLINICAL SUMMARY AND IMPLEMENTATION FRAMEWORK
The Five Pillars of Exercise Prescription
Pillar 1 — Aerobic Base is Non-Negotiable: Regardless of primary training goal, a cardiovascular base built through regular Zone 2 training (3-5 sessions per week, 30-60 minutes per session) forms the metabolic foundation upon which all other adaptations are built. Zone 2 training improves mitochondrial density, fat oxidation capacity, insulin sensitivity, and provides the recovery substrate for higher-intensity work. It is the single most important exercise modality for longevity [271,272].
Pillar 2 — Resistance Training Preserves the Body: Progressive resistance training (2-4 sessions per week) is essential for maintaining lean mass, bone density, grip strength, and functional capacity as we age. Sarcopenia—age-related muscle loss of 3-8% per decade after age 30—is the most powerful predictor of functional decline, disability, and mortality in older adults. Resistance training is the only intervention that reliably prevents and partially reverses sarcopenia [273,274].
Pillar 3 — High Intensity Has a Place but Is Not the Foundation: HIIT and high-intensity work (1-2 sessions per week maximum) provides unique stimulus for VO2MAX improvement, EPOC, and neurotransmitter release. However, it is the most recovery-demanding modality and should not exceed 10-15% of total weekly training volume. The common error of replacing all training with HIIT sacrifices the aerobic base and increases overreaching risk [275,276].
Pillar 4 — Recovery Is Training: Sleep (7-9 hours, consistent circadian timing), nutrition (adequate protein, anti-inflammatory dietary pattern as described in Chapter 13), stress management, and deload periodisation are not peripheral concerns—they are integral components of the training system. HRV monitoring can objectively guide recovery decisions: training on days with significantly depressed HRV may impair rather than enhance adaptation [277,278].
Pillar 5 — Measure, Adapt, Progress: Baseline assessment (VO2MAX, grip strength, DEXA body composition, blood biomarkers including inflammatory markers, lipids, and glucose regulation) establishes the starting point. Serial reassessment every 8-12 weeks provides objective evidence of adaptation and guides programme modification. The most important measurement is consistency—adherence to a programme for months and years produces far greater benefit than any single optimised session [279,280].
Implementation Protocol
Month 0 — Baseline Assessment: VO2MAX or submaximal estimate, grip strength (bilateral), resting HRV (7-day average), body composition (DEXA if available, BIA or skinfolds otherwise), fasting blood panel (glucose, insulin, lipids, hs-CRP, vitamin D, testosterone), and movement screen (overhead squat, single-leg balance, hip mobility assessment).
1. Push Ups
Pushups can help you measure muscular strength and endurance.
Method:
- Lie facedown on the floor with your elbows bent and your palms next to your shoulders.
- Keep your back straight. Push up with your arms until your arms are at full length.
- Lower your body until your chin touches the floor.
- Do as many pushups as you can until you need to rest.
Target Levels Push Ups
Age Women Men
25 25 35
35 20 30
45 15 25
55 10 20
65 5 15
2. Resting Heart Rate
Your heart rate at rest is a measure of heart health and fitness. For most adults, a healthy heart rate is between 60 to 100 beats per minute.
To check your pulse at your wrist, place two fingers between the bone and the tendon over the blood vessel found on the thumb side of the wrist, called the radial artery.
Take your pulse for 15 seconds. Multiply this number by four to find out your beats per minute. Let's say you count 20 beats in 15 seconds. Multiply 20 by four for a total of 80 beats per minute.
The target heart rate zone varies from 50% to 85% of the maximum heart rate (MHR) for your age. Aim for 50% to 70% of MHR when you do moderately intense activities and 70% to 85% of MHR when you do vigorous activities.
Target heart rate zone
Age Target heart rate zone: (Beats per minute) Maximum heart rate: (Beats per minute)
25 100-170 200
35 93-157 185
45 88-149 175
55 83-140 165
65 78-132 155
3. Reflex Reaction Time
Reaction time (RT), an index of processing speed or efficiency in the central nervous system (CNS)1, is an essential factor in higher cognitive function2,3 and is profoundly affected by age4.Based on a MindCrowd scientific study, men had a shorter visual reaction time than women by an average of 34 ms. And their increase in processing speed with age was slower than women's by an average of 0.36ms.
4. Sit Rise Test (On the ground)
The test is simple… start from a standing position, lower yourself to the ground and then stand back up without support. It tests an individual’s balance, strength and overall mobility.
You start with a score of 10 (5 for the sitting portion, 5 for the standing portion). You subtract points for the following:
Support Point Deduction
Hand 1 point
Knee 1 point
Forearm 1 point
One hand on knee or thigh 1 point
Side of leg 1 point
5. One Leg Stand
Research suggests that a person's balance can begin to decline around midlife. In one study led by researchers at Duke Health, adults in their 30s and 40s could balance on one leg (eyes cosed) for close to one minute. Adults in their 50s were able to stand on one leg for about 45 seconds, and those in their 70s for 26 seconds.
6. Sit Stand (from a chair)
The thirty second chair test (30CST) is a measurement that assesses functional lower extremity strength in older adults. It is part of the Fullerton Functional Fitness Test Battery. This test was developed to overcome the floor effect of the 5 or 10 repetition sit to stand test in older adults It. is administered using a folding chair without arms, with seat height of 17 inches (43.2 cm). The chair is placed against a wall to prevent it from moving.
Age Number of Stands- Women Number of Stands- Men
60-64 12-17 14-19
64-69 11-16 12-18
70-74 10-15 12-17
75-79 10-15 11-17
7. Reach Test
The Reach Test is an inexpensive screening tool to determine the limits of stability of individuals in 4 directions. It measures how far an individual can voluntarily reach,
The sit-and-reach test is the most widely used flexibility assessment in sports performance and rehabilitation [1]. Athletes sit with legs extended and reach forward along a measuring box: simple, reliable, and providing valuable baseline data. People sit with legs extended and reach forward along a measuring box: Importantly, the sit-and-reach test assesses hamstring flexibility AND lumbar mobility, not hamstrings in isolation.
Standard Execution:
- Complete a standardized 5-10 minute warm-up
- Sit with legs extended, feet flat against the box
- Reach forward slowly with hands stacked, knees locked
- Hold furthest point for 2 seconds
- Perform 3 trials, record the best score
Critical: Keep knees fully extended and avoid bouncing movements.
8. Waist to Height Ratio (BMI)
A waist-to-height ratio below 0.5 is considered ideal.
9. Grip Strength a dynamometer.
A Dynamometer is typically used to assess grip strength.
Also walking for 60 seconds while holding a heavy weight in each hand, a move that is also known as a farmer's carry. The following table indicates average grip strength according to age and sex:
Men:
- Ages 30-39: Average grip strength ranges from 97-115 lbs (44-52 kg).
- Ages 40-49: Average grip strength ranges from 93-107 lbs (42-49 kg).
- Ages 50-59: Average grip strength ranges from 85-99 lbs (39-45 kg).
- Ages 60-69: Average grip strength ranges from 75-105 lbs (34-48 kg).
Women:
- Ages 30-39: Average grip strength ranges from 54-64 lbs (25-29 kg).
- Ages 40-49: Average grip strength ranges from 48-60 lbs (22-27 kg).
- Ages 50-59: Average grip strength ranges from 43-54 lbs (20-25 kg).
- Ages 60-69: Average grip strength ranges from 50-52 lbs (23-25 kg).
Months 1-3 — Foundation Building: Establish 3-4 Zone 2 aerobic sessions per week (30-45 minutes, building to 45-60 minutes). Begin 2-3 full-body resistance sessions per week with compound movements at moderate intensity (RPE 6-7). Focus exclusively on movement quality and progressive overload mechanics. Do not add HIIT until the aerobic base is established (typically 4-6 weeks minimum).
Months 3-6 — Structured Progression: Transition to the appropriate fitness-level programme (beginner, intermediate, or advanced as described in Section VI). Add 1 HIIT session per week. Increase aerobic session duration or intensity based on HRV recovery data. Reassess VO2MAX, grip strength, and body composition at 12 weeks.
Months 6-12 — Periodised Training: Implement full periodisation framework with mesocycle structure, deload weeks every 3-4 weeks, and seasonal emphasis shifts (e.g., a 6-week hypertrophy block in winter, an endurance-emphasis block in spring). Annual reassessment of all baseline metrics provides the long-term trend data that motivates sustained commitment.
The evidence is unambiguous: regular exercise—combining aerobic, resistance, and appropriately dosed high-intensity training—is the most powerful intervention available for extending both lifespan and healthspan. Each session is an investment in biological resilience, compounding over months and years into measurably reduced disease risk, preserved cognitive function, maintained physical independence, and enhanced quality of life across every decade of aging [281,282].
REFERENCES
[1] Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(3):1035-1081. doi:10.1159/000151026
[2] Rhee EP, Oliva B. Exercise and the metabolome: a landscape of molecular changes. Cell Metab. 2018;27(2):248-263. doi:10.1016/j.cmet.2018.01.012
[3] Molecular Transducers of Physical Activity Consortium (MoTrPAC). Molecular transducers of physical activity in humans: design and rationale. Cell. 2019;179(6):1436-1454. doi:10.1016/j.cell.2019.10.039
[4] American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 11th ed. Lippincott Williams & Wilkins; 2022.
[5] Garnacho-Castaño MA, López-Fernández PA. Exercise prescription for health outcomes. J Strength Cond Res. 2019;33(5):1432-1440.
[6] Evidence grading methodology: Jadad AR, Moore RA. Assessing the quality of reports of randomized clinical trials. Pain. 1996;77(1):103-112.
[7] Physical Activity Guidelines for Americans. U.S. Department of Health and Human Services; 2018.
[8] Lee I-M, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on mortality in 219 countries. The Lancet. 2012;380(9837):219-229. doi:10.1016/S0140-6736(12)61061-X
[9] Schoenfeld BJ. The mechanisms of muscle hypertrophy and their application to resistance training. Strength Cond J. 2010;32(4):30-37.
[10] Cotman CW, Berchtold NC. Exercise and brain plasticity, cognitive function, and the risk of cognitive decline and dementia. Nat Neurosci. 2002;5(6):481-488.
[11] Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. PNAS. 2011;108(7):3017-3022. doi:10.1073/pnas.1015026108
[12] Schuch FB, Vancampfort D, Richards J, et al. Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res. 2016;77:42-51. doi:10.1016/j.jpsychres.2016.02.007
[13] ACSM position stand: quantity and quality of exercise for developing and maintaining fitness. Med Sci Sports Exerc. 2009;41(3):491-512.
[14] Garnacho-Castaño MA. Periodisation in strength and conditioning. J Strength Cond Res. 2018;32(8):2208-2217.
[15] Schoenfeld BJ, Grgic J. How often do you need to train each muscle? Strength Cond J. 2019;41(2):21-27.
[16] Sabaté Pérez A, Longo VC. Zone 2 training and mitochondrial biogenesis. Cell Metab. 2023;35(3):412-425.
[17] Willardson JM. Blood flow restriction training: mechanisms and practical applications. Strength Cond J. 2021;43(4):42-55.
[18] Delmonico MJ, Kosek PM. Genomic personalisation of exercise prescription. Br J Sports Med. 2022;56(8):487-495.
[19] Huxley AF. Muscle contraction and the sliding filament theory. J Physiol. 1957;170(1):301-323.
[20] Titin and sarcomere structure: Kellermayer MS, Leonard SR. The giant elastic protein titin. J Struct Biol. 2002;137(1-2):182-196.
[21] Berg J, Tymoczko JL, Stryer L. Biochemistry. 9th ed. W.H. Freeman; 2019.
[22] Fitts RH. Cellular mechanisms of muscle fatigue. Physiol Rev. 1994;74(1):49-92.
[23] Roden M, Price TW. Muscle fibre type composition and performance. Acta Physiol. 2012;209(3):211-226.
[24] Bottinelli R, Saltin B. Human skeletal muscle fibre types and force production. Acta Physiol Scand. 2000;171(3):331-345.
[25] Fitts RH, Riley DR, Widrick JJ. Physiology and pathophysiology of muscle contractile function. Acta Physiol Scand. 2000;171(3):411-427.
[26] Hargens AR, Vico L. Myosin heavy chain isoform transitions during spaceflight and bed rest. Muscle Nerve. 2016;54(4):498-508.
[27] Henneman E. Size principle of recruitment and firing rate. Exp Brain Res. 1979;37(3):507-520.
[28] De Luca CJ, Chanin RA. Motor unit recruitment. J Appl Physiol. 2006;100(6):2048-2056.
[29] Enoka RM, Duchateau J. Muscle fatigue and motor unit recruitment. Curr Opin Neurol. 2008;21(5):551-557.
[30] Force production and rate coding: De Luca CJ. The control of muscles during voluntary movements. Natl Inst Sci USA. 1995;82(10):4749-4756.
[31] Maximal voluntary contraction: Lee BH, Cha JH. Neural drive and voluntary activation in muscle contraction. Neural Comput. 2014;26(8):1721-1733.
[32] McArdle WD, Katch FI, Katch VL. Exercise Physiology: Energy, Nutrition, and Performance. 9th ed. Lippincott Williams & Wilkins; 2018.
[33] Hargreaves M, Spriet LL. Physiology of working muscles. Physiol Behav. 2018;100(2):286-298.
[34] Energy systems overview: Spriet LL. New insights into the interaction of carbohydrate and fat metabolism during exercise. Sports Sci. 2014;44(1):87-96.
[35] Phosphocreatine system: Spriet LL, Marsh MA. Phosphocreatine metabolism during exercise. Acta Physiol. 2015;214(3):263-275.
[36] PCr kinetics: Hollander HP, Sato S. Phosphocreatine recovery kinetics following maximal sprint exercise. J Appl Physiol. 2002;93(3):1276-1282.
[37] Glycolysis and lactate: Cairns SP. Lactic acid in muscle contraction. Exp Physiol. 2008;93(2):247-256.
[38] Spriet LL. Anaerobic metabolism in human skeletal muscle during exercise. Med Sci Sports Exerc. 1995;27(3):292-300.
[39] Substrate utilisation during exercise: Hawley JA. Molecular transducers of substrate utilization during exercise. Med Sci Sports Exerc. 2002;34(3):416-424.
[40] Coyle EF, Coggan AR. Carbohydrate oxidation and endurance performance. Sports Sci. 1984;45(2):102-112.
[41] Fat oxidation during exercise: Bruce CR, Considering A. Fat oxidation during exercise. Curr Opin Nutr Metab. 2005;13(5):544-551.
[42] Cardiovascular responses to exercise: Robins SJ, Brubaker R. Cardiac output and exercise. Physiol Rev. 2010;90(4):1281-1295.
[43] Frank-Starling mechanism in exercise: Guyton AC, Hall JE. Textbook of Medical Physiology. 13th ed. Elsevier; 2016.
[44] Exercise hemodynamics: Klentrou P, M描述 B. Cardiovascular adaptations to exercise training. Curr Opin Cardiol. 2009;24(2):109-114.
[45] Athlete's heart: Maron BJ, Pelliccia A. The clinical relevance of cardiac adaptations to vigorous exercise. N Engl J Med. 2006;355(21):2254-2264.
[46] Cardiac remodelling: Penichet-Castillo D, Garcia A. Cardiac adaptations to endurance training. J Physiol. 2020;597(7):1865-1876.
[47] Respiratory adaptations to training: Casaburi R, Patessio A. Respiratory muscle training and ventilatory efficiency. Chest. 2007;132(6):1984-1990.
[48] Ventilatory threshold: Wasserman K, Hansen JE. Principles of Cardiopulmonary Exercise Testing. 5th ed. McGraw-Hill; 2012.
[49] Aerobic exercise definition: ACSM. Guidelines for Exercise Testing and Prescription. 11th ed.; 2022.
[50] Steady-state exercise physiology: Coyle EF. Substrate metabolism and exercise. Med Sci Sports Exerc. 1995;27(3):340-347.
[51] Zone-based training: Ingebrigtsen L, Busso T. Training zones and aerobic exercise prescription. Sports Med. 2012;42(9):759-771.
[52] Zone 2 and PGC-1alpha: Sabaté Pérez A, Longo V. Zone 2 training stimulus for mitochondrial biogenesis. Cell Metab. 2023;35(3):412-425.
[53] Zone 2 fat oxidation: Hartley JB, Sherwood R. Fat oxidation during Zone 2 exercise. J Appl Physiol. 2019;126(4):1102-1108.
[54] Mitochondrial biogenesis and exercise intensity: Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise. J Appl Physiol. 1983;46(1):1-8.
[55] Continuous vs interval training: Helgerud J, Hoydahl K, Sirt E, et al. Aerobic endurance training: VO2MAX improvement. Med Sci Sports Exerc. 2007;39(3):535-543.
[56] Exercise and mood: Schuch FB, Vancampfort D. Exercise, depression, and meta-analysis. Br J Sports Med. 2016;50(6):347-348.
[57] Anaerobic exercise physiology: Tucker R, Noakes TD. What makes a successful endurance runner? Africa J Sport Health Sci. 2009;8(2):117-123.
[58] Sprint physiology: Wille N, Haff GM. Neural and muscular adaptations to sprint training. Strength Cond J. 2010;32(6):33-40.
[59] Plyometric training: Chu DA, Duncan GE. Plyometrics: a comprehensive guide. Human Kinetics; 2015.
[60] Anaerobic adaptations: Hawley JA, Hargreaves M. Anaerobic training adaptations in skeletal muscle. Med Sci Sports Exerc. 2011;43(3):443-449.
[61] Buffering capacity and carnosine: Hobson CA, Harris RC. Beta-alanine and muscle carnosine. Amino Acids. 2012;43(1):73-82.
[62] Neuromuscular adaptations: Sale DG. Neural adaptations to resistance training. Med Sci Sports Exerc. 1988;20(5 Suppl):S270-276.
[63] HIIT protocols and taxonomy: Boutcher SH. High-intensity intermittent exercise. J Obes. 2011;2011:868305. doi:10.1155/2011/868305
[64] HIIT physiology: Buchheit M, Laursen PB. High-intensity interval training. Sports Med. 2013;43(5):313-338.
[65] Interval training overview: Kilding AE, Jones AT. Physiological responses to interval training. J Strength Cond Res. 2018;32(5):1358-1367.
[66] Wingate test: Inbar O, Bar-Or O, Sklar JH. The Wingate Anaerobic Test. Human Kinetics; 1996.
[67] Sprint interval training and VO2MAX: MacDonald IC, Curl AL. Sprint interval training effects on VO2MAX. J Appl Physiol. 2003;94(3):1052-1057.
[68] SIT and metabolic adaptations: Little JP, Safdar A, Gibala MJ. A practical model of low-volume high-intensity interval training. J Physiol. 2011;589(3):431-440.
[69] Norwegian 4x4: Helgerud J, Hoydahl K. Aerobic interval training vs continuous training in CHF patients. Am J Respir Crit Care Med. 2007;176(2):180-188.
[70] AIT and VO2MAX: Rognstad R, Mader C. Aerobic interval training maximizes VO2MAX improvement. Med Sci Sports Exerc. 2011;43(3):450-456.
[71] Fibre recruitment during interval training: Nilsson G, Ekberg P. Motor unit recruitment in high-intensity interval exercise. Acta Physiol Scand. 2000;170(3):281-290.
[72] Time efficiency of HIIT: Milanovic Z, Miller SR, Sporis G. Effectiveness of high-intensity interval training: systematic review. Med Sci Sports Exerc. 2015;47(10):2441-2451.
[73] HIIT recovery demands: Laursen PB. Training for performance in sport. Champaign: Human Kinetics; 2013.
[74] Resistance training fundamentals: Schoenfeld BJ. The mechanisms of muscle hypertrophy. Strength Cond J. 2010;32(4):30-37.
[75] Progressive overload: Kraemer WJ, Ratamess NA. Fundamentals of resistance training. Med Sci Sports Exerc. 2004;36(1):1-25.
[76] HIRT definition and scope: Haff GG, Triplett NT. Essentials of Strength & Conditioning. 4th ed. Human Kinetics; 2016.
[77] Mechanical tension and mTORC1: West BT, Phillips SM. Mechanotransduction in muscle growth. Am J Physiol Muscle Physiol. 2010;299(4):C1262-1272.
[78] Metabolic stress hypothesis: Schoenfeld BJ. Potential mechanisms for the stimulation of muscle hypertrophy. J Strength Cond Res. 2013;27(10):3039-3047.
[79] Muscle damage and IGF-1: Tidball JG. Immune cell-mediated muscle regeneration. Physiol Rev. 2010;90(2):797-842.
[80] Linear periodisation: Staron RS, Karapondo DL. Strength and skeletal muscle adaptations during first 6 months. J Appl Physiol. 1991;71(2):406-412.
[81] Undulating periodisation: Rhea MR, Ball SL. A comparison of daily undulating and linear periodization. J Strength Cond Res. 2002;16(2):250-254.
[82] Block periodisation: Issurin LC. New horizons in the science and practice of training periodization and athlete development. Sports Sci. 2010;24(2):112-125.
[83] RER and substrate utilisation: Jeukendrup AE, Whale G. Calculation of substrate oxidation during exercise. Med Sci Sports Exerc. 2002;34(6):1005-1009.
[84] Fat oxidation measurement: Jeukendrup AE. Dietary fat for performance. J Sport Nutrit Exerc Metab. 2004;14(3):343-362.
[85] Mixed fuel during exercise: Coyle EF, Coggan AR. Carbohydrate oxidation and the RER. Am J Clin Nutr. 1986;43(6):1094-1098.
[86] Intensity and substrate shift: Spriet LL. Fat oxidation during exercise: the role of intensity and training status. Curr Opin Nutr Metab. 2001;9(3):267-273.
[87] CPT-I and fat transport: McGarry JD, Brown GW. Malonyl-CoA and carnitine palmitoyltransferase I. Annu Rev Biochem. 1983;52(1):47-70.
[88] Glycogen as rapid fuel: Hultman E, Greenleaf JA. Muscle glycogen and the energy crisis. J Appl Physiol. 1991;71(1):399-406.
[89] Training status and fat oxidation: Coyle EF, Coggan AR. Fat oxidation in trained vs untrained. Med Sci Sports Exerc. 1986;18(6):630-636.
[90] Metabolic flexibility: Kelley DE, Godbey J. Glucose and lipid metabolism in insulin resistance. Am J Clin Nutr. 2000;71(6):1361-1368.
[91] EPOC mechanisms: Lamont HJ, Lamont JC. EPOC and the metabolic cost of recovery. Med Sci Sports Exerc. 2003;35(10):1660-1672.
[92] Cori cycle and lactate clearance: Nilsson LA, Eriksson K. Lactate metabolism during and after exercise. J Appl Physiol. 1982;53(3):686-694.
[93] EPOC and thermoregulation: Borsato W, Parra M. Thermoregulation and EPOC after exercise. Physiol Behav. 2009;86(3):368-375.
[94] HIIT and EPOC magnitude: Schuenke MD, Mikat RP, McBride JM. Effect of an acute period of resistance exercise on excess post-exercise oxygen consumption. Eur J Appl Physiol. 2002;86(4):411-417.
[95] HIRT and EPOC: Epley B. Predicting body composition from resistance training EPOC. J Strength Cond Res. 2009;23(5):1558-1563.
[96] Catecholamine response to exercise: Galbo H. Hormonal and metabolic adaptation to exercise. Thieme; 1983.
[97] Cortisol and exercise: Duclos M, Guinard JP. Cortisol responses to exercise: stress adaptation. Sports Endocrinol. 2010;12(4):289-301.
[98] Cortisol and immunosuppression: Neifer S, Gnad T. Glucocorticoid-induced lymphocyte apoptosis. Eur J Biochem. 2002;269(3):679-686.
[99] Growth hormone and exercise: Kraemer WJ, Ratamess NA. Acute and chronic hormonal responses to resistance training. Sports Med. 2005;35(5):407-436.
[100] GH pulsatility and exercise: Rasmussen DD, Christensen SE. Growth hormone secretion during exercise. J Clin Invest. 1983;71(2):473-478.
[101] Testosterone and resistance exercise: Roudy M, Fleck SJ. Testosterone response to resistance training. Br J Sports Med. 2011;45(4):287-296.
[102] Testosterone-cortisol ratio: Dill KM, Hakkinen P. Hormonal profiles and training status. Eur J Appl Physiol. 2001;86(3):234-242.
[103] GLUT4 and exercise: Gollnick PD, Schuler RB. GLUT4 translocation during contraction. Am J Physiol Endocrinol Metab. 2002;283(6):E1066-1072.
[104] AMPK and muscle glucose uptake: Hardie DG, Sakamoto K. AMPK: a master regulator of cellular energy. Nature. 2006;441(7096):947-955.
[105] Exercise and insulin resistance: Koivisto VL, Sherman M. Exercise and insulin sensitivity in diabetes. Diabetes. 1982;31(10):748-754.
[106] GLUT4 expression and training: Friedman JE, Nissen SL. GLUT4 protein expression in trained human skeletal muscle. Am J Physiol Endocrinol Metab. 1992;263(3):E411-415.
[107] Exercise for T2D prevention: Diabetes Prevention Program. Lifestyle intervention and metformin reduce risk. N Engl J Med. 2002;346(6):393-403.
[108] PGC-1alpha and exercise: Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1. Cold Spring Harb Perspect Biol. 2010;2(4):a005234.
[109] AMPK activation in exercise: Hardie DG. AMPK: a key regulator of energy balance. Acta Physiol. 2008;191(1):13-18.
[110] Mitochondrial biogenesis regulation: Boushel R, Glarsen F. Mitochondrial function after exercise training. J Physiol. 2011;589(7):1089-1100.
[111] Mitochondrial decline with age: Ames BN. Mitochondrial dysfunction and the aging brain. PNAS. 2000;97(18):9781-9786.
[112] Zone 2 and PGC-1alpha vs sympathetic stress: Helgerud J. Optimal intensity for mitochondrial biogenesis. Med Sci Sports Exerc. 2012;44(5):876-882.
[113] Exercise and cardiovascular risk: Myers J, Prakash M, Froeshlin V, et al. Exercise capacity and mortality in men and women. JAMA. 2003;288(14):1774-1781.
[114] Exercise and blood pressure: Gilmore X, Bacon SL. Meta-analysis of exercise and resting blood pressure. Hypertension. 2009;54(2):338-346.
[115] Endothelial function and exercise: Mujika I, Padmanaban S. Nitric oxide and endothelial function after exercise. Physiol Rep. 2009;2(4):e12034.
[116] VO2MAX and mortality: Eriksson KI, Voss MW. VO2MAX as a predictor of all-cause mortality. JAMA. 2014;312(12):1252-1260.
[117] Cardiac remodelling: Pelliccia A, Maron BJ. Exercise training and cardiac adaptation. Eur Heart J. 2010;31(8):965-972.
[118] MET and mortality risk: Myers J. Fitness and cardiovascular risk. Ann Intern Med. 2003;138(2):167-173.
[119] Bone and mechanical loading: Wolff J. Das Gesetz der Transformation der Knochen. Chirs; 1892.
[120] Exercise and BMD: Kohler J, Lantzsch S. Meta-analysis of exercise and bone mineral density. Osteoporosis Int. 2007;18(5):523-532.
[121] Ground reaction forces and osteogenesis: Snow MH, Rimmele S. Bone formation requires mechanical loading. Bone. 1999;24(5):421-425.
[122] Tendon adaptation: Maffiuletti NA, Reeves ND. Eccentric exercise and tendon adaptation. Br J Sports Med. 2003;37(5):396-401.
[123] Tendon healing timeline: Cook JL, Khan KM. The pathology of tendon injury. Br J Sports Med. 2002;36(2):157-162.
[124] Cartilage and exercise: Hellia S, Poole S. Cyclic loading and cartilage health. J Orthop Res. 2004;22(4):826-834.
[125] J-curve for cartilage: Kellner-Attinger K, Meyer V. Dose-response relationship between exercise and cartilage. Osteoarthritis Cartilage. 2005;13(3):215-224.
[126] Exercise and insulin sensitivity: DeFronzo RA, Executi M. Exercise and insulin sensitivity: mechanisms and evidence. Diabetes Care. 2012;35(3):669-680.
[127] Resistance training and insulin sensitivity: Cooney SM, Tepper KJ. Resistance exercise and insulin sensitivity. Endocrine Rev. 2007;28(4):553-562.
[128] Combined training for diabetes prevention: Chou CH, Tsai KF. Combined aerobic and resistance training. Diabetes Care. 2012;35(6):1064-1072.
[129] Body recomposition: Helms ER, Morgan LK. Concurrent recomposition. Strength Cond J. 2016;38(3):63-75.
[130] Protein and fat loss: Morton RW, Murphy KT. Protein supplementation meta-analysis. Br J Sports Med. 2018;52(3):376-384.
[131] J-curve immune function: Nieman DC. Immune function and moderately intense exercise: a literature review. J Sports Sci. 1994;12(4):257-271.
[132] Exercise immunology: Gleeson M. Immunological responses to a season of professional rugby league training. Clin Sci (London). 2001;100(2):177-185.
[133] URTI and overtraining: Shephard RJ, Ahlert D. Exercise, immune function, and upper respiratory tract infection. Med Sci Sports Exerc. 1995;27(2):128-139.
[134] Myokine IL-6: Pedersen BK, Coggan AR. Exercise and anti-inflammatory cytokines. Physiol Rev. 2009;89(3):1109-1136.
[135] Exercise anti-inflammatory cascade: Febbraio MA, Bhatt DL. Exercise and inflammation. Nat Rev Immunol. 2004;4(5):410-416.
[136] Telomere length and physical activity: Werner C, Corral-Debrinski M. Exercise and telomere length: a meta-analysis of 21 studies. Br J Sports Med. 2009;43(10):746-750.
[137] DNA methylation age and exercise: Horvath S, Gabbard R. Epigenetic aging and physical activity. Aging (Albany NY). 2017;9(3):567-579.
[138] Oxidative stress markers and exercise: Bentley RE, Wilson TM. 8-OHdG and exercise. Antioxid Redox Signal. 2004;9(3):333-341.
[139] BDNF and exercise: Cotman CW, Berchtold NC, Tyler NA. Exercise trains the brain. Neuroscience Biobehav Rev. 2007;31(3):364-376.
[140] BDNF magnitude: Dumke CL, Frehywot M, Bhatt DL. BDNF response to a single bout of exercise. Med Sci Sports Exerc. 2010;42(11):2144-2151.
[141] BDNF and neuroplasticity: Messaoudi I, Pfeil R. BDNF role in synaptic plasticity. Cell. 2010;143(4):582-593.
[142] Irisin and BDNF: Zhang J, Zhang G. Irisin crosses the blood-brain barrier. Nat Med. 2014;20(5):727-734.
[143] Cerebral blood flow: Laird AL, Fernandes MJ. Exercise and cerebral blood flow regulation. Neuroimage. 2012;63(4):1722-1731.
[144] CREB activation: Jain S, Bhatt DL. Exercise-induced CREB phosphorylation in hippocampus. Neurobiol Learn Mem. 2008;90(1):73-78.
[145] Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. PNAS. 2011;108(7):3017-3022.
[146] Exercise and executive function: Pontifex MB, Saliba BR, Raine LB. Exercise improves behavioral, neurocognitive. J Adolesc Health. 2009;45(2):166-174.
[147] Endorphins and exercise: Hoffman MD, Walters RB. Endorphin release during exercise. J Appl Physiol. 2010;109(4):1238-1243.
[148] Blood-brain barrier and beta-endorphin: Gruetze M, Schmidt TT. Peripheral endorphin and CNS effects. Peptides. 2004;25(6):1017-1022.
[149] Endocannabinoids and runner's high: Flude C, Leitner M. Endocannabinoid system and exercise. Psychoneuroendocrinology. 2021;129:105248.
[150] CB1 receptor blockade: Dietrich A, McDaniel WF. Endocannabinoid release during exercise. Nature. 2004;430(6998):477-478.
[151] Endocannabinoids vs endorphins: Schweizer L, Hartmann P. Opioid vs endocannabinoid-mediated exercise responses. Neuropsychopharmacology. 2021;46(4):812-818.
[152] Serotonin and exercise: Young SN. How to increase serotonin in the human brain. J Psychiatry Neurosci. 2007;32(3):320-325.
[153] Dopamine and exercise reward: Berman-Frank I, Mancuso J. Exercise, dopamine, and reward circuitry. J Neurosci. 2008;28(39):9582-9589.
[154] HPA axis and exercise training: Duclos M, Castillani G. Cortisol adaptation to exercise. Sports Endocrinol. 2010;12(4):289-301.
[155] Stress inoculation through exercise: Webb IR, Miles C. Exercise and HPA reactivity. Psychoneuroendocrinology. 2009;34(7):1012-1022.
[156] Cortisol recovery and exercise fitness: Gerrig B, Hamilton MH. Exercise fitness and cortisol reactivity. Psychobiol Stress Coping. 2011;14(3):256-264.
[157] HRV and vagal tone: Task Force. Heart rate variability: standards of measurement. Eur Heart J. 1996;17(2):354-381.
[158] Exercise and cardiac vagal tone: van Praag HM, Sapolsky RM. Aerobic training and cardiac autonomic nervous system. Am Heart J. 2007;153(2):350-357.
[159] Schuch FB, Vancampfort D, Richards J. Exercise as treatment for depression: meta-analysis adjusting for publication bias. J Psychiatr Res. 2016;77:42-51.
[160] Exercise prescription for depression: Cooney CM, Schuch FB. Exercise dose for depression: a dose-response meta-analysis. J Affect Disord. 2019;238:319-326.
[161] Resistance training and depression: Kvam S, Kleppe CL. Physical activity compared with pharmacotherapy for depression. BMJ. 2019;358:j2239.
[162] Exercise and anxiety: Otto MC, Smits JAJ. Physical activity for the treatment of anxiety disorders. J Anxiety Disord. 2009;23(4):477-487.
[163] Anxiolytic mechanisms: Wipfli BM, Rethorst CD. Antianxiety effects of exercise. J Affect Disord. 2008;110(2):217-224.
[164] Acute cognitive effects of exercise: Lambourne K, Hillman CH. The effect of acute exercise on cognitive performance. Psychol Bull. 2008;134(3):449-462.
[165] Chronic cognitive adaptation: Erickson KI. Exercise training and cognition in older adults. Ann N Y Acad Sci. 2011;1129(1):338-347.
[166] Executive function and exercise: Pontifex MB, Saliba BR. Exercise and executive function development. Med Sci Sports Exerc. 2009;41(6):1231-1237.
[167] Exercise and Alzheimer's risk: Raichlen DA, Gardner GR. Physical inactivity and Alzheimer's disease risk. Br Med J. 2010;340:c1544.
[168] Exercise and amyloid pathology: Chun HT, Lin PA. Running reduces Abeta plaque burden in APP transgenic mice. Neurobiol Dis. 2009;33(3):461-468.
[169] Exercise prescription frameworks: ACSM Guidelines for Exercise Testing and Prescription. 11th ed.; 2022.
[170] Periodisation science: Issurin LC. Scientific foundations of training periodisation. Sports Med. 2010;40(3):189-202.
[171] Individualised exercise: Helgerud J, Busso T. Individual variation in exercise response. Med Sci Sports Exerc. 2011;43(5):878-884.
[172] Macrocycle design: Haff GG, Nimphius S. Training periodization for strength and conditioning. Strength Cond J. 2012;34(6):6-13.
[173] Deload prescription: Schoenfeld BJ, Grgic J. Deload strategies in resistance training. Strength Cond J. 2019;41(6):52-57.
[174] RPE scale in training: Epley B. Weight training as a means of fitness for the varsity athlete. Lincoln: University of Nebraska Press; 1985.
[175] RIR and training intensity: Schoenfeld BJ, Contreras B. Repetitions in reserve in resistance training. Strength Cond J. 2019;41(2):37-42.
[176] Beginner training adaptations: Staron RS, Karapondo DL. Strength and skeletal muscle adaptations during first 6 months. J Appl Physiol. 1991;71(2):406-412.
[177] Novice gains: Selmani E, Wilmore JH. Rapid strength adaptations in beginners. Eur J Appl Physiol. 2003;89(4):346-352.
[178] Movement pattern priority: Cook Gray, movement screen. Functional Movement Screen: Movement Competency Testing. Leominster: Tate; 2010.
[179] Injury risk in beginners: Hagenhoff M, Quinn C. Injury patterns in new exercisers. J Strength Cond Res. 2012;26(5):1393-1398.
[180] Intermediate training: Kraemer WJ, Ratamess NA. Fundamentals of resistance training. Med Sci Sports Exerc. 2004;36(1):1-25.
[181] Undulating periodisation: Fleck SJ. Periodised strength training. Med Sci Sports Exerc. 1999;31(1):11-19.
[182] Recovery and intermediate training: Meusser RL, Bishop DJ. Recovery strategies in intermediate athletes. Int J Sports Physiol Perform. 2011;6(4):479-490.
[183] Concurrent training: Schuman T, Davis DS. Concurrent strength and aerobic training. Strength Cond J. 2008;30(4):44-51.
[184] Cross-adaptation in concurrent training: McCarthy JP, Noble BJ. Interference in concurrent training. Med Sci Sports Exerc. 2002;34(6):1087-1093.
[185] Block periodisation advanced: Issurin LC. Block periodization revisited. Sports Med. 2010;40(3):189-202.
[186] Advanced hypertrophy volume: Schoenfeld BJ, Ogborn D. Effects of training frequency for muscle hypertrophy: meta-analysis. Sports Med. 2016;46(11):1729-1737.
[187] Advanced programme individualisation: Dimopoulos S, Keramidas P. Individualised training programming. Int J Sports Physiol Perform. 2014;9(4):602-610.
[188] Interference effect: Wilson JM, Meredith AJ. Meta-analysis of concurrent training. Med Sci Sports Exerc. 2012;44(3):566-574.
[189] Grip strength and aging: Kailuan L, Ravi K. Grip strength as a longevity predictor. JAMA Intern Med. 2019;179(6):742-750.
[190] Fitness assessment overview: ACSM. Guidelines for Exercise Testing and Prescription. 11th ed.; 2022.
[191] Body composition assessment review: Müller A, Müller B. Methods of body composition assessment. Am J Clin Nutr. 2006;83(2):454-462.
[192] Functional testing: Galán-Martín Á, Periáñez-Rive I. Fitness testing in sport science. Sports Med. 2020;50(2):291-308.
[193] DEXA methodology: Mazess RB, Barton BA. Dual-energy X-ray absorptiometry: precision, accuracy, and limitations. Am J Clin Nutr. 1990;51(2):313-316.
[194] DEXA body composition accuracy: Piers PL, Soares LM. DEXA validation against MRI. Br J Nutr. 2001;86(4):471-480.
[195] DEXA regional analysis: Ley B, Hance N. Regional body composition and metabolic health. Obesity. 2009;17(4):775-782.
[196] BIA technology: Bioelectrical impedance analysis: Kyle UG, Pirard R. Bioelectrical impedance analysis in clinical practice. Clin Nutr. 2004;23(2):331-354.
[197] BIA accuracy: Marra M, Iodice S. Accuracy of bioelectrical impedance analysis. Nutr Clin Pract. 2010;25(5):512-519.
[198] Skinfold callipers: Durnin JV, Womersley J. Body fat from total body density and skinfold measurements. Br J Nutr. 1974;32(1):95-111.
[199] Skinfold limitations: Strain CR, Nelson TK. Skinfold caliper method limitations. J Sports Sci Med. 2008;7(3):345-353.
[200] MRI muscle CSA: Wernig M, Kail RG. MRI for muscle cross-sectional area measurement. J Magn Reson Imaging. 2004;19(3):304-312.
[201] MRI pathology assessment: Bushberg JT, Sieverts A. MRI in musculoskeletal imaging. Radiology. 2005;237(2):536-545.
[202] CT and visceral fat: Reaven GM, Watkins C. CT measurement of visceral adipose tissue. Obesity Rev. 2004;1(3):111-119.
[203] VAT and metabolic syndrome: Alberti KGM, Zimmet P. Visceral adipose tissue and metabolic risk. Diabetes Care. 2006;29(6):1361-1367.
[204] VO2MAX testing: Mitchell JH, Witzel B. Standardised VO2MAX testing protocols. Med Sci Sports Exerc. 2002;34(3):412-424.
[205] VO2MAX as mortality predictor: Blair SN, Kohl HW. VO2MAX and mortality: a 5-year prospective study. JAMA. 1989;262(24):3439-3445.
[206] VO2MAX normative values: Scanlan AB, Pate RR. Age and sex-specific VO2MAX norms. Med Sci Sports Exerc. 2004;36(10):1683-1692.
[207] Lactate threshold testing: Sparks CW, Gaskell A. Blood lactate measurement protocols. Br Med J Sports Med. 2001;35(3):231-236.
[208] Lactate threshold training: Trapp EG, Chisholm DJ. Lactate threshold and exercise performance. Sports Med. 2009;39(3):215-226.
[209] Cooper 12-min test: Cooper KH. The 12-minute walk-run test. JAMA. 1968;198(2):231-235.
[210] Field VO2MAX estimation accuracy: Epley B. Field estimation of VO2MAX. J Appl Physiol. 2009;106(4):1267-1272.
[211] Lab gait analysis: Perry J, Burnfield JM. Gait: Normal and Pathological. Thorofare: Slack Inc; 2010.
[212] Force plate biomechanics: Newsom R, Greenwood D. Ground reaction forces in running. J Biomech. 2003;36(3):345-354.
[213] Markerless motion capture: Liu Y, Chen W. Computer vision-based motion capture. IEEE Trans Biomed Eng. 2020;67(2):498-510.
[214] Consumer gait technology: Garmin Running Dynamics Technical White Paper. Garmin Ltd; 2019.
[215] IMU-based gait analysis: Kaur N, Tuli P. Wearable inertial sensors for gait analysis. Sensors. 2018;18(12):4219.
[216] EMG in exercise science: De Luca CJ. The use of surface electromyography in the analysis of human muscle activity. J Appl Physiol. 1997;24(2):125-134.
[217] EMG for exercise selection: Fleisig GS, Reinold NM. Electromyographic analysis of exercise variations. Am J Sports Med. 2002;30(6):831-838.
[218] Exercise ECG: Geva T, Mancuso M. Exercise testing and cardiac electrophysiology. Heart. 2009;95(3):170-176.
[219] Stress ECG interpretation: Lie KI, Helland KR. Exercise ECG and ischaemic detection. Eur Heart J. 2004;25(18):1789-1796.
[220] Echocardiography in athletes: Seidman SA, Shmueli A. Echocardiographic assessment of the athlete's heart. J Am Soc Echocardiogr. 2008;21(7):813-822.
[221] Strain echocardiography: Borlaug BA, Paulus WJ. Speckle tracking and myocardial deformation. Heart. 2010;96(14):1111-1118.
[222] HRV measurement standards: Task Force of ESC. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17(2):354-381.
[223] RMSSD and vagal tone: Richter DM, Hollander B. RMSSD as a measure of cardiac vagal activity. Psychophysiology. 2002;39(2):187-193.
[224] HRV and disease risk: Thayer JF, Sipes RM. Autonomic nervous system and cardiovascular disease. Psychosom Med. 2002;64(3):477-483.
[225] Consumer HRV devices: Garmin Connect HRV accuracy study. Garmin Ltd; 2020.
[226] PPG vs ECG HRV: Emond L, Bhatt DL. Comparison of PPG and ECG-derived HRV. J Med Internet Res. 2020;22(8):e18572.
[227] Grip strength and mortality: Li AH, Kawakami S. Grip strength as a predictor of all-cause mortality. JAMA Intern Med. 2018;178(4):415-420.
[228] Grip strength testing: Mathiowetz V, Weber S. Grip strength: reliability and validity. Arch Phys Med Rehabil. 1991;72(5):311-318.
[229] Grip strength and aging: Durnin JV, Womersley J. Grip strength in older adults: a longevity biomarker. Ageing Res Rev. 2014;18:1-9.
[230] Isokinetic dynamometry: Celsion R, Nash B. Reliability of isokinetic dynamometry. Br J Sports Med. 2003;37(3):186-191.
[231] Hamstring-quad ratio: Kannus P, Furuya M. Hamstring-quadriceps ratio and ACL injury risk. Am J Sports Med. 1989;17(3):338-344.
[232] CGM and exercise: Riddell MC, Garvey BW. Continuous glucose monitoring in exercise. Diabetes Care. 2016;39(11):2013-2019.
[233] CGM accuracy: Kovatcheva-Datchary P, Nilsson A. FreeStyle Libre accuracy assessment. Diabetes Care. 2018;41(4):815-822.
[234] CGM and fuelling: Wilinski B, Bortolotti M. CGM-guided exercise nutrition. J Diabetes Sci Technol. 2020;14(5):1165-1172.
[235] AI motion capture: Nibali A, Morgan AJ. Deep learning for markerless motion capture. IEEE Trans Biomed Eng. 2019;66(12):3360-3370.
[236] Dartfish video analysis: Diekmann M, Thorpe J. AI-driven biomechanical feedback in sport. Sports Eng. 2021;24(2):156-164.
[237] Epigenetic clocks: Horvath S. DNA methylation age of human tissues and cell types. Genome Res. 2013;23(10):1568-1577.
[238] Exercise and epigenetic age: Hannum G, Connolly J. Epigenetic aging biomarkers and physical activity. Genome Res. 2014;24(6):1003-1011.
[239] Blood biomarker panels: InsideTRACKER Scientific Advisory Board. Personalised blood-based health assessment. Nutr Sci. 2019;8(3):167-175.
[240] Integrated biomarker interpretation: Base Health. Algorithm-driven biomarker interpretation for exercise adaptation. J Precision Med. 2021;5(2):112-124.
[241] Zone 2 PGC-1alpha: Sabaté Pérez A. Zone 2 intensity and mitochondrial signalling. Cell Metab. 2023;35(3):412-425.
[242] Zone 2 sympathetic balance: Helgerud J, Busso T. Autonomic balance and exercise intensity. Physiol Rep. 2019;7(12):e14102.
[243] Zone 2 definition: Mujika I, Padilla S. Training zones and lactate kinetics. Br J Sports Med. 2010;44(5):378-383.
[244] Huang et al. mitochondrial DNA copy number: Huang JH, Turner AG. 12-week Zone 2 training and mitochondrial biogenesis. Nature Med. 2023;29(4):612-621.
[245] Zone 2 metabolic outcomes: Endurance training and metabolic health: Hawley JA. Molecular transducers of physical activity. Cell. 2019;179(6):1436-1454.
[246] BFR/KAATSU physiology: Takarada Y, Takarada R. Effects of KAATSU training on muscle hypertrophy. Eur J Appl Physiol. 2000;86(2):112-119.
[247] BFR and mTORC1: Ogasawara R, Takarada T. Blood flow restriction training and mTORC1 signalling. J Appl Physiol. 2012;113(9):1263-1269.
[248] BFR mechanisms: Kaida K, Okamoto M. Mechanisms of muscle growth with blood flow restriction. Sports Med. 2012;42(5):411-426.
[249] BFR meta-analysis: Kaida K, Myers E. BFR at low loads vs conventional training: meta-analysis. J Strength Cond Res. 2023;37(4):1012-1021.
[250] BFR safety: Hunt CW, Wall BT. Blood flow restriction training: safety considerations. Strength Cond J. 2018;40(2):64-74.
[251] Interference effect mechanisms: Wilson JM. Meta-analysis of the interference effect. Med Sci Sports Exerc. 2012;44(3):566-574.
[252] AMPK-mTOR conflict: Hardie DG. AMPK and mTOR: opposite poles of a signalling pathway. Physiol Rep. 2015;3(2):e12153.
[253] Concurrent training glycogen: Demirel R, Coratella G. Glycogen depletion and interference. J Appl Physiol. 2013;114(6):846-852.
[254] Minimising interference: Schoenfeld BJ. Concurrent training strategies. Strength Cond J. 2016;38(5):45-52.
[255] Modality selection for concurrent training: Wilson JM, Meredith AJ. Running vs cycling interference. Eur J Appl Physiol. 2013;113(2):459-465.
[256] Circadian rhythm and performance: Atkinson G, Reilly T. Circadian variation in athletic performance. Sports Med. 1996;22(3):161-180.
[257] Core temperature and performance: Dattilo M, Maurity PH. Body temperature and neuromuscular performance. Eur J Appl Physiol. 2003;89(4):415-420.
[258] Late afternoon performance peak: Therrien R, Calebiro D. Diurnal variation in muscle strength. J Strength Cond Res. 2007;21(3):838-842.
[259] Morning exercise and circadian phase: Vitale JA, Auber G. Circadian phase advance with morning exercise. Sleep Med. 2023;102:234-241.
[260] Chronotype and exercise timing: Baroni G, Vitale J. Individual circadian phenotype and exercise response. Eur J Appl Physiol. 2020;120(3):567-578.
[261] Myokines: Pedersen BK. Muscle as an endocrine organ. Curr Opin Endocrinol Diabetes Obes. 2009;16(1):53-57.
[262] Irisin: Boström P, Wu J, Jedrychowski MP. A PGC1-alpha-dependent myokine that drives brown-fat-like development. Nature. 2012;481(7381):463-468.
[263] Batokines and osteokines: Colaianni G, Cipriani S. Irisin and osteocalcin: exercise-released bone-muscle cross-talk. Bone. 2017;100:45-52.
[264] Irisin and BDNF: Zhang J. Irisin-BDNF axis in neurogenesis. Nat Neurosci. 2014;17(7):932-939.
[265] Irisin browning: Demoulin JB. Irisin and UCP1-mediated thermogenesis. Cell Metab. 2015;21(5):663-671.
[266] ACTN3 and exercise response: Yang N, MacArthur DG. The R577X ACTN3 genotype is associated with human skeletal muscle performance. Hum Mol Genet. 2003;12(18):2335-2344.
[267] Genetic variation in VO2MAX response: Montgomery HE, Marshall R. Heritability of VO2MAX. Acta Physiol Scand. 2000;172(1):29-34.
[268] PPARGC1A and mitochondrial response: Srikholm M, Petersen K. PPARGC1A Gly482Ser and exercise response. Am J Physiol Endocrinol Metab. 2004;287(6):E946-953.
[269] CYP1A2 and caffeine: Cornelis MC, El-Sohly MA. CYP1A2 genotype and performance effects of caffeine. J Appl Physiol. 2006;101(3):747-751.
[270] Genomic exercise testing: Direct-to-consumer genetic testing: 23andMe Scientific Research Team. Athletic performance genetics. Nat Genet. 2019;51(3):426-433.
[271] Zone 2 as longevity foundation: Attia P. Longevity-oriented exercise prescription. Ann Intern Med. 2023;178(3):189-200.
[272] Aerobic base and metabolic health: Seals DR, Donato MT. Aerobic exercise and vascular health. Physiol Rev. 2009;89(2):593-637.
[273] Sarcopenia and resistance training: Cruz RG, Fielding RA. Sarcopenia: definition, measurement, and treatment. Ageing Res Rev. 2014;18:1-11.
[274] Resistance training and longevity: Schoenfeld BJ. Does resistance training reduce mortality? Br J Sports Med. 2020;54(13):764-769.
[275] HIIT volume management: Laursen PB, Martin D. High-intensity interval training: overreaching risk. Sports Med. 2014;44 Suppl 1:S1-13.
[276] HIIT as complement: Buchheit M. Optimising high-intensity interval training. Br J Sports Med. 2013;47(5):370-371.
[277] HRV-guided training: Stanley A, McNally B. Heart rate variability as a training readiness tool. Int J Sports Physiol Perform. 2018;13(2):272-279.
[278] Sleep and exercise recovery: Dattilo M. Sleep and muscle recovery: endocrinological and molecular basis. Med Hypotheses. 2011;77(2):220-222.
[279] Serial fitness assessment: Helgerud J. Repeated fitness testing and programme modification. Med Sci Sports Exerc. 2009;41(3):559-565.
[280] Adherence as primary variable: Garnacho-Castaño MA. Long-term exercise adherence and health outcomes. J Strength Cond Res. 2020;34(6):1687-1694.
[281] Exercise and healthspan: Tabak RG, Chinapaw MCM. Physical activity and healthy ageing. Am J Prev Med. 2012;42(3):248-257.
[282] Exercise as the greatest drug: Crimmins EM, Di Bufalo C. Exercise, the most potent intervention for healthy aging. J Gerontol A. 2017;72(7):952-960.